Next Article in Journal
Targeting Transcriptional Regulators Affecting Acarbose Biosynthesis in Actinoplanes sp. SE50/110 Using CRISPRi Silencing
Next Article in Special Issue
Identification and Pathogenicity of Fusarium Species from Herbaceous Plants on Grassland in Qiaojia County, China
Previous Article in Journal
Gram Negative Biofilms: Structural and Functional Responses to Destruction by Antibiotic-Loaded Mixed Polymeric Micelles
Previous Article in Special Issue
Endophytic Fungi Co-Culture: An Alternative Source of Antimicrobial Substances
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

In Vitro Antioxidant and Antibacterial Activities of Ethyl Acetate Extracts of Ziziphus lotus Leaves and Five Associated Endophytic Fungi

1
Natural Resources Laboratory, Faculty of Biological and Agronomic Sciences, Mouloud Mammeri Univesity, Tizi-Ouzou 15000, Algeria
2
Laboratory of Analytic Biochemistry and Biotechnology (LABAB), Department of Biochemistry and Microbiology, Faculty of Biological and Agronomic Sciences, Mouloud Mammeri University, Tizi-Ouzou 15000, Algeria
3
Westerdijk Fungal Biodiversity Institute, Uppsalalaan, 3584 CT Utrecht, The Netherlands
4
Laboratoire de Maitrise des Energies Renouvelables, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia, Bejaia 06000, Algeria
5
cE3c—Center for Ecology, Evolution and Environmental Changes & CHANGE—Global Change and Sustainability Institute, Faculdade de Ciências da Universidade de Lisboa Campo Grande, 1749-016 Lisboa, Portugal
*
Author to whom correspondence should be addressed.
Microorganisms 2024, 12(12), 2671; https://doi.org/10.3390/microorganisms12122671
Submission received: 5 November 2024 / Revised: 15 December 2024 / Accepted: 20 December 2024 / Published: 23 December 2024
(This article belongs to the Special Issue Endophytic Fungus as Producers of New and/or Bioactive Substances)

Abstract

:
The exploration of new pharmacological compounds from endophytic fungi offers infinite possibilities. The aim of this study was to evaluate the antibacterial and antioxidant activities of extracts from the leaves of Ziziphus lotus and five of its endophytic fungi and investigate the chemical diversity of the secondary metabolites produced. Isolated, purified, and molecularly identified endophytes and plant leaves were subjected to ethyl acetate extraction. The antibacterial potential of the extracts was assessed by the disc diffusion method against five bacterial strains: Staphylococcus aureus ATCC 25923; Staphylococcus aureus MU50; Enterococcus faecalis WDCM00009; Escherichia coli ATCC 25922; and Pseudomonas aeruginosa ATCC 27853. DPPH and reducing power tests were performed to assess antioxidant potential. GC–MS analysis was used to identify volatile compounds in extracts. Fungal endophytes were identified as Aspergillus cavernicola, Aspergillus persii, Alternaria alternata, Cladosporium asperlatum, and Fusarium incarnatum–equiseti complex, with respective accession numbers DTO 412-G6, DTO 412-I5, DTO 413-E7, DTO 412-G4, and DTO 414-I2. GC–MS analysis revealed a large number of bioactive compounds. All extracts showed antibacterial activity against at least two of the bacteria tested, and most showed antioxidant activity. The Aspergillus cavernicola extract stood out for its higher phenolic content and higher antioxidant and antibacterial activities in all tests.

1. Introduction

Recently, research into developing new safe drugs from natural resources has been explored in depth [1]. Medicinal plants have been used to isolate and characterize bioactive metabolites directly. However, the discovery of endophytic fungi within these plants with the ability to produce the same compounds as the host plant or even different metabolites has shifted the focus of new drug sources from plants to fungi [2]. Endophytic fungi colonize the inter- and intra-cellular tissues of plants without causing any apparent damage or disease symptoms [3]. These fungi are found in almost all plants in natural ecosystems and have complex mutual ecological relationships with their host plants [4]. These fungi are capable of producing heterogeneous low molecular weight compounds, also known as secondary metabolites [5]. These are an abundant and valuable source of molecules with a wide variety of chemical structures and biological activities [6], including antitumor, anti-inflammatory, antibacterial, antiviral, antioxidant, and anti-angiogenic [7,8]. Active compounds isolated from endophytic fungi include penicillin, an antibiotic produced by the species Penicillium notatum [9], taxol, and vincristine, recognized antineoplastic agents produced by the endophytic fungi Taxomyces andreanae and Fusarium oxysporum [10].
Currently, serious infections caused by bacteria and their resistance to antibiotics are one of the greatest threats to human health [11]. In addition, oxidative stress is caused by free radicals and is involved in pathophysiological events, including some human diseases such as diabetes mellitus, aging, atherosclerosis, Alzheimer’s disease, and Parkinson’s disease [12]. Exploring natural sources for new bioactive agents may provide leads or solutions for the discovery and development of new drugs [13]. Endophytic fungi play an important role in the search for natural bioactive compounds and could represent an alternative source for the production of therapeutic agents that are difficult to obtain by chemical synthesis. The exploitation of new pharmacological compounds from endophytes is infinite [14].
Ziziphus lotus L. (Desf), commonly known as Sedra, is a medicinal plant belonging to the Rhamnaceae family, abundant in the Mediterranean region, from Libya to Morocco, Algeria, and Southern European countries such as Spain, Italy, Greece, and Cyprus [15]. The antioxidant, immunosuppressive [15], antibacterial [16], antifungal [17], anti-inflammatory, analgesic [18], and antiulcer [19] properties of this plant have been demonstrated in previous studies.
In this study, we were interested in the isolation and identification of endophytic fungi from the leaves of Z. lotus, the evaluation of the antibacterial activity of ethyl acetate extracts of isolated fungi and leaves against human pathogens, and the evaluation of the antioxidant activity of the two types of extracts and finally their analysis by GC–MS.

2. Materials and Methods

2.1. Plant Material

The leaves of Z. lotus were collected from eight healthy, randomly selected plants in the region of Djebla, Tizi-Ouzou, Northern Algeria, in March 2016. Leaves were stored at 4 °C and processed within 48 h of their collection for the isolation of endophytic fungi. Moreover, a quantity of leaves is dried and powdered.

2.2. Isolation and Identification of Endophytic Fungi

Endophytic fungi were isolated from the leaves of Z. lotus, as described by Ghazi-Yaker et al. (2023) [20]. Five strains belonging to some of the most popular genera of endophytic fungi (Aspergillus, Fusarium, Cladosporium, and Alternaria) were selected for this study. Molecular identification was carried out using the ITS region and a reference GenBank’s database as described by Ghazi-Yaker et al. (2023) [20]. The sequences were compared on GenBank using BLAST and in the in-house sequence database of Westerdijk Fungal Biodiversity Institute (Utrecht, The Netherlands).

2.3. Secondary Metabolites Extraction

2.3.1. Secondary Metabolites Extraction from Z. lotus Leaves

A total of 10 g of air-dried leaf powder was placed in 100 mL of ethyl acetate on a rotary shaker at 350 rpm for 8 h. A filtration through a sterile compress was carried out, followed by a centrifugation at 4000 rpm for 15 min, and the solvent was evaporated using a rotary evaporator at 40 °C. The extracted residue was dissolved in dimethyl sulfoxide (DMSO 10%) to a final concentration of 20 mg/mL, sterilized by filtration through 0.22 µm Millipore filters, and stored at 4 °C to be used as a stock solution for studying the biological activities.

2.3.2. Secondary Metabolites Extraction from Fungal Endophytes

The secondary metabolite extraction from fungi was performed according to the protocol used by Lee et al., 2019 [21]. Endophytic fungi were cultured on potato dextrose agar (PDA) at room temperature for seven days. Five pieces of pure mycelial agar plugs were inoculated aseptically into a 500 mL Erlenmeyer flask containing 100 mL of previously autoclaved potato dextrose broth (PDB). After fermentation (30 days and at room temperature with periodic stirring at 150 rpm for 1 to 2 h), the culture broth was separated from the mycelia by filtration. Culture filtrates were extracted three times with ethyl acetate. The organic phase was collected by decantation and then concentrated under pressure by evaporation of the solvent using a rotary evaporator at 40 °C. The dried extracts were dissolved in dimethyl sulfoxide (DMSO 10%) to a final concentration of 20 mg/mL, sterilized by filtration through 0.22 µm Millipore filters, and stored at 4 °C to be used as a stock solution for studying the biological activities.

2.4. In Vitro Biological Activities Testing

2.4.1. Antibacterial Activity

Disc Diffusion Assay

The ethyl acetate extracts of plants and fungi were screened for antibacterial activity against five human pathogenic bacteria. They contained both Gram-positive (Staphylococcus aureus ATCC 25923, Staphylococcus aureus MU50, and Enterococcus faecalis WDCM00009) and Gram-negative bacterial strains (Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853). All of the bacteria in this experiment were supplied by the microbiology laboratory of MOULOUD MAMMERI University (Tizi-Ouzou, Algeria).
Before testing, the bacteria strains were sub-cultured in Petri dishes containing nutrient agar. After 18 h of incubation at 37 °C, suspensions with an optical density between 0.08 and 0.1 at λ = 625 nm were prepared for each microorganism in sterile physiological water. The agar disc diffusion method [22] was used to investigate the antibacterial activity of all ethyl acetate extracts. For this purpose, the freshly prepared bacterial suspensions are swabbed on sterile Muller–Hinton Petri dishes. Sterilized Whatman paper discs (6 mm) containing 25 μL of each ethyl acetate extract were placed on the surface of the seeded Muller–Hinton. The plates were kept at 4 °C for two hours to facilitate the diffusion of the secondary metabolites from discs, and then they were incubated at 37 °C. After 24 h of incubation, the presence around the discs of a circular inhibition zone in which there is no growth of microorganisms denotes their sensitivity to this extract. The diameter of the inhibition zones is measured using a ruler. The larger the zone of inhibition, the more sensitive the bacteria. Chloramphenicol discs (30 μg) are used as a positive control. Negative controls were prepared with the same solvent used to dissolve the extracts (DMSO 10%). All experiments were carried out in triplicate (n = 3), and results are reported as mean ± SD values.

Determination of Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC)

The micro-dilution method [23] is used to determine the minimum inhibitory concentration (MIC). The MIC values were determined for the bacterial strains that were sensitive to the extracts in the disc diffusion assay. The inocula of the bacterial strains were prepared from 10-hour-old broth cultures, and suspensions were adjusted to 0.5 McFarland standard turbidity. Dilution series ranging from 10 to 0.004 mg/mL in Muller–Hinton Broth (MHB) are prepared. In each well of a 96-well plate, 20 μL of the bacterial strain is applied, 60 μL of Muller–Hinton Broth, and 80 μL of a dilution of extract already prepared. Thus, the dilutions are reduced by half and go from 5 to 0.002 mg/mL. Wells serving as negative control do not contain extract, and those serving as positive control contain the extract without bacterium. The plates are then incubated at 37 °C for 18 h. For the detection of the MIC, 5 μL of resazurin (0.015%) is added to each well. The MIC is the smallest concentration of the extract, which does not produce a change in resazurin color and which corresponds to the absence of bacterial growth.
MBC (minimum bactericidal concentration) is the minimum concentration of the extract capable of killing the inoculum. It is determined by inoculating on Muller–Hinton Agar medium, 10 µL aliquots taken from the wells where there has been no change in the color of the resazurin and the MBC corresponds to the smallest concentration, which gives no subculture.

2.4.2. Antioxidant Assays

Two different assays, including free radical scavenging DPPH assay and reducing power assay, were used to evaluate the antioxidant potential of the endophytic fungal extracts. The total phenolic content was tested by Folin–Ciocalteau reagent-based assay.

DPPH (1,1-Diphenyl-2-Picrylhydrazyl) Assay

The evaluation of the scavenging power of the extracts is carried out according to the protocol described by Yadav et al., 2014 [24]. Concentrations of fungal and plant extract (10, 30, 50, 100, 200, 300, 400, 600 µg/mL) in DMSO 10% and DPPH (0.1 mM) in ethanol were prepared. Different concentrations of ascorbic acid were used as the standard. A total of 2 mL of DPPH solution was added to the different test samples (0.2 mL) and incubated in darkness for 30 min at room temperature. The absorbance was measured at 517 nm by a Spectrophotometer UVmini-1240 (Shimadzu, Suzhou, Jiangsu, China). The ethanol solvent is used as a blank, and the absorbance of the DPPH radical without antioxidants served as the control. The percentage inhibition was calculated according to the following equation:
% inhibition = 100 × [(Absorbance of control – Absorbance of sample)/Absorbance of control]
The amount of sample necessary to decrease the absorbance by 50% of DPPH (IC50) was calculated graphically by linear regression. All experiments were carried out in triplicate, and results are reported as mean values.

Reducing Power Assay

The evaluation of the reductive potential of the extracts is carried out according to the protocol described by Oyaizu (1986) [25]. A total of 1 mL of the concentration (1 mg mL−1) of samples and standard was mixed with phosphate buffer (2.5 mL, pH 6.6), and potassium ferricyanide (K3Fe (CN)6) (2.5 mL, 1%) was added to the mixtures. After incubation at 50 °C for 20 min in a water bath, the reaction was stopped by the addition of 2.5 mL of 10% trichloroacetic acid. The mixture was then centrifuged at 1000× g for 8 min. A total of 2.5 mL of the supernatant was mixed with the same volume of distilled water and 0.5 mL of a 0.1% iron chloride (FeCl3) solution. The absorbance was measured at λ = 700 nm against a similarly prepared blank, replacing the test compound with DMSO 10%, which allowed for the calibration of the spectrophotometer UVmini-1240 (Shimadzu, Suzhou Jiangsu, China). A high absorbance value indicates greater reducing power. Ascorbic acid was used as standard. All experiments were performed in triplicates. Results were reported as mean ± SD values.

Determination of Total Phenolic Content

The total phenol content of ethyl acetate extracts was estimated using the Folin–Ciocalteu reagent-based assay using gallic acid as standard [24]. To 1 mL of each extract (1 mg/mL), 500 µL of (50%) Folin–Ciocalteu reagent was added, followed by the addition of 1.5 mL of 20% Na2CO3. The final volume was 5 mL made by adding distilled water. The mixture was incubated at room temperature for 30 min, and the absorbance of the developed color was recorded at 765 nm using a spectrophotometer UVmini-1240 (Shimadzu, Suzhou Jiangsu, China). The same procedure was repeated with 1 mL aliquots of 10 to 70 µg/mL gallic acid solutions in DMSO 10% used as standard for the calibration curve. The total phenolic value was obtained from the regression equation and expressed as mg/g gallic acid equivalent.

2.5. Identification of Bioactive Constituents by GC–MS

Analysis of volatile compounds was performed using GC–MS. It is carried out on a chromatograph MASTER GC- Fast Gas Chromatograph System (DANI Instruments, Milan, Italy) coupled to a MASTER TOF MS A-Plus mass spectrometer (DANI Instruments, Milan, Italy) with electronic impact with an ionization energy of 70 eV. The chromatograph is equipped with an HP-1MS capillary column (30 m × 0.25 mm × 0.25 µm). The stationary phase consists of 1% Phenyl and 99% dimethylpolysiloxane. The carrier gas is pure helium 6.0 with a flow rate of 0.5 mL/min. The column is programmed at the following temperatures: 70 °C for 5 min; then, an increase of 10 °C/min to 300 °C is carried out. The volume of the injected solution is 1 µL in Splitless mode. The temperature of the interface and the source is 200 °C.
Chromatograms and mass spectra were recorded. Compounds are detected according to their order of elution. They are identified using their retention time and their mass spectrum compared to data from the NIST (National Institute of Standards and Technology, Gaithersburg, MD, USA) library. The identified compounds were then subject to a bibliographic search for their biological activities.

2.6. Statistical Analysis

All values are expressed as arithmetic means ± standard deviations (SD). The statistical significance of any difference in each parameter among the antioxidant essays was evaluated by analysis of variance (ANOVA) using Stat Box 6.40 software. p-values of less than 0.05 were considered statistically significant.

3. Results

3.1. Fungal Strains Identification

Five species were identified as follows:
Cladosporium asperulatum: Identification based on partial actin and elongation factor 1-alpha sequences. DTO 412-G4 has a 100% similarity with actin and TEF (Act, 225/225 nt; TEF, 431/431 nt) sequences generated from the type of Cladosporium asperulatum;
Aspergillus cavernicola: Identification based on partial tubulin sequence. DTO 412-G6 has a 100% (422/422) similarity with the BenA sequence generated from the A. cavernicola type strain (CBS 117.76, EF652332);
Aspergillus persii: Identification based on partial tubulin sequences. DTO 412-GI5 has a 99.6% (546/548) similarity with the BenA sequence generated from the A. persii type strain (MUCL 41970, AY819988);
Alternaria alternata: More barcodes are needed to confidentially identify this strain at the species level. Identification based on partial ITS and TEF sequences;
Fusarium incarnatum equiseti complex: Identification based on ITS. In order to obtain a better ID, a TEF and RPB2 sequence needs to be generated.

3.2. Antibacterial Potential of Extracts

The antibacterial activity of endophytic fungi and leaf extracts was tested in vitro by disc diffusion (Figure 1, Table 1). The leaf extract of Z. lotus showed no inhibitory activity against the bacteria tested, with the exception of strains of S. aureus, with which a weak zone of inhibition was noted (8 mm).
All the extracts of endophytic fungi isolated from Z. lotus had inhibitory effects on at least four of the bacteria tested. The zones of inhibition obtained varied from 9 to 32 mm. The fungal extracts were more effective on Gram-positive bacteria than on Gram-negative bacteria. In fact, of the two Gram-negative strains used, the fungal extracts were more active against E. coli ATCC 25922 with a larger inhibition zone of 25 mm obtained with A. cavernicola, whereas for P. aeruginosa ATCC 27853, only the A. cavernicola extract showed activity.
The A. cavernicola extract was the only one capable of inhibiting the five bacteria tested. It is also remarkable that the largest zones of inhibition were obtained with this same extract against the Gram-positive bacteria tested (32, 31, 33, and 30 mm against S. aureus ATCC 25923, S. aureus MU50, and E. faecalis WDCM00009, respectively). These zones were also larger than those obtained with the standard antibiotic used (31 mm, 25 mm, and 25 mm, respectively).
The resulting MIC and MBC of the five endophytic fungi crude extracts against tested pathogenic bacteria are depicted in Table 2.
Interestingly, A. cavernicola showed a broad spectrum of antibacterial activity, with the MIC ranging from 0.078 to 0.625 mg/mL. The MIC test indicated that the concentration of A. cavernicola extract required to prevent the growth of the test microbes was found to be as follows: 0.078 mg/mL against E. coli ATCC 25922, E. faecalis WDCM00009, and S. aureus ATCC 25923; 0.312 mg/mL against S. aureus MU50; and 0.625 mg/mL against P. aeruginosa ATCC 27853. The MBC of extract against all the microbes ranged from 1.25 to 5 mg/mL. Aligiannis et al. (2001) [26] proposed a classification of MICs, which stated that strong inhibitors had MIC values < 0.5 mg/mL, moderate inhibitors had MIC values between 0.6 and 1.5 mg/mL, and weak inhibitors had MIC values above 1.6 mg/mL. Based on this classification, A. cavernicola reveals a moderate activity against P. aeruginosa ATCC 27853 and a strong activity against the remaining four strains. A. persii exhibited strong activity against E. faecalis WDCM00009 (0.078 mg/mL), S. aureus ATCC 25923, and E. coli ATCC 25922 (0.312 mg/mL), and moderate activity against S. aureus MU50.
On the other hand, A. alternata exhibited strong activity (0.312 mg/mL) against both S. aureus used and moderate activity against E. faecalis WDCM00009 and E. coli ATCC 25922 (0.625 mg/mL). F. incarnatum–equiseti complex exhibited moderate activity against the tested bacteria in the range of 0.625–1.25 mg/mL. The MBC values of Fusarium were greater than 5 mg/mL. C. asperlatum showed strong activity against E. coli ATCC 25922 (0.312 mg/mL) and moderate activity against S. aureus ATCC 25922 (1.25 mg/mL). Remarkably, all extracts of endophytic tested inhibited the growth of S. aureus MU50 (hospital-acquired MRSA, vancomycin-intermediate S. aureus, VISA) with MIC of 0.312 mg/mL for A. cavernicola and A. alternata, 1.25 mg/mL for F. incarnatum–equiseti complex and A. persii and 2.5 mg/mL for C. asperlatum, respectively.

3.3. Antioxidant Potential of Extracts and Phenolic Content

3.3.1. DPPH Assay

The reaction was visible as a color change from purple to yellow. Concerning the ascorbic acid, the leaf extract, and the fungal extract of A. cavernicola, A. alternata, and A. persii, increasing concentration showed a dose-response scavenging effect. Concerning F. incarnatum–equiseti complex and C. asperlatum, none demonstrated DPPH scavenging antioxidant potential (Figure 2). The analysis of variance (ANOVA) between all the extracts showed a very highly significant difference (p-value = 0). After ascorbic acid, the extract of A. cavernicola exhibited the greatest activity at the lowest IC50 concentration (309.57 ± 7.59 µg/mL), followed by Z. lotus (IC50 = 355.68 ± 4.31 µg/mL), A. alternata (IC50 = 535.67 ± 3.21 µg/mL), and A. persii (IC50 = 1253.59 ± 11.09 µg/mL).

3.3.2. Reducing Power Assay

The resulting reducing power of endophytic fungi and Z. lotus leaf ethyl acetate extracts is shown in Figure 3.
In reducing power assay, reducing ability is measured by a change in Fe 3+ to Fe 2+. The analysis of variance (ANOVA) between all the extracts showed a very highly significant difference (p-value = 0). After ascorbic acid, the extract of A. cavernicola presented the highest absorbance values (0.61), followed by Z. lotus (0.28), indicating their greater reductive potential and electron donor ability for stabilizing free radicals in comparison with the other extracts, A. persii and A. alternata, with the same absorbance value of 0.18. Concerning C. asperlatum and F. incarnatum–equiseti complex, the absorbance values are low (0.02 and 0.01), attesting to the absence of reducing activity.

3.3.3. Determination of Total Phenolic Content

According to the analysis of variance (ANOVA) obtained for total phenolic compounds, a very highly significant difference (p-value = 0) was observed between all the extracts. Concentrations obtained varied from 6.4 to 125.32 mg/g gallic acid equivalent. A higher amount of phenolic compounds was determined and quantified in A. cavernicola extract. In fact, A. cavernicola contained a twofold higher polyphenol content (125.32 mg/g gallic acid equivalent) in comparison with Z. lotus (59.64 mg/g gallic acid equivalent), followed by A. alternata (46.07 mg/g gallic acid equivalent) and A. persii (33.62 mg/g gallic acid equivalent), whereas F. incarnatum–equiseti complex and C. asperlatum extracts contained considerably less concentration of phenols (7.9 and 6.4 mg/g respectively) (Figure 4).

3.4. Identification of Bioactive Compounds by GC–MS

The GC–MS analysis was used to identify volatile compounds in the extracts. The GC–MS is a unanimously accepted method for the analysis of phyto-constituents. It is also often used in the analysis of fungal extracts. Based on the results of antibacterial and antioxidant activities, the extracts of endophytes A. cavernicola, A. persii, and A. alternata were selected for this analysis in addition to plant extract. GC–MS analysis of all extracts revealed a totality of 72 different compounds, shown in Table 3.
GC–MS analysis conducted on the crude ethyl acetate extract of A. cavernicola revealed 26 bioactive compounds and showed the following main compounds: Butylphosphonic acid, 2-ethylhexyl propyl ester (37.468%); 4-tert-Octylphenol, TMS derivative (10.892%); 2,3-Dimethyl-2-heptene (8.4199%); and 5,6-Dihydropenicillic acid (7.1999%). The following compounds are found only in the A. cavernicola extract: 2,3-Dimethyl-2-heptene; Hexadecanoic acid, 1-[[[(2-aminoethoxy) hydroxyphosphinyl] oxy] methyl]-1,2-ethanediyl ester; 5-Hydroxy-4-methoxy-5-(prop-1-en-2-yl)furan-2(5H)-one; 2-Nonen-4-one; 2-(4-Ethoxyanilino)-N-propylpropanamide, Ac derivative; Butylphosphonic acid, 2-ethylhexyl propyl ester; 4-tert-Octylphenol, TMS derivative; 1H-Imidazole, 1-(1-oxooctadecyl)-; 2-(1-Methylpiperidin-2-yl) ethanol; 4-(4-Hydroxyphenyl)-4-methyl-2-pentanone, TMS derivative; Sydowinin A, 2TMS derivative; Hexanedioic acid, dioctyl ester; Phenanthrene-10-ethanamine, 3-bromo-á-hydroxy-N,N-diheptyl-; O,O-diphenylphosphate; Cyclodecasiloxane, eicosamethyl.
GC–MS study carried out on the crude ethyl acetate extract of A. persii revealed 28 bioactive compounds, the most important being 2,5-furandicarboxylic acid, tetrahydro-, dimethyl ester (21.4686%); phosphinic acid, (1,1-dimethylethyl)[4-(1,1-dimethylethyl)phenyl]- (15.0705%); 2,5-hexadienoic acid, 3-methoxy-5-methyl-4-oxo-(penicillic acid) (11.5193%); l-alanine, N-(3-fluorobenzoyl)-, heptyl ester (10.3966%). The following compounds are found only in the A. persii extract: Cyclopentane, 1-acetyl-1,2-epoxy-; Flucytosine; 2-Benzyl-3-methoxycyclopropane carboxylic acid, methyl ester; Succinic acid, ethyl 4-methylhept-3-yl ester; 5-Hydroxy-4-methoxy-3-(1-methoxypropan-2-yl)furan-2(5H)-one; Erythritol, 2,5-Furandicarboxylic acid, tetrahydro-, dimethyl ester; Epinephrine; (á)-, 3TMS derivative; l-Alanine, N-(3-fluorobenzoyl)-, heptyl ester; Phthalic acid, butyl hex-3-yl ester; Ethene-1,1-diamine, 2,2-dinitro-; 3-Cholestanol piperidinomethyl ether; Pentanedioic acid, 1-(6-bromo-9-phenanthrenyl)-2-(diheptylamino)ethyl monoester; Hexasiloxane, tetradecamethyl-.
Moreover, the compounds Penicillic acid (2,5-Hexadienoic acid, 3-methoxy-5-methyl-4-oxo; Succinic acid, ethyl pent-4-en-2-yl ester; 5,6-Dihydropenicillic acid; Cholestan-5-en-3-ol piperidinomethyl ether; and Phosphinic acid, (1,1-dimethylethyl)[4-(1,1-dimethylethyl)phenyl]-) are found only in fungal extracts belonging to the genus Aspergillus (A. cavernicola and A. persii).
GC–MS analysis conducted on the crude ethyl acetate extract of A. alternata revealed 31 bioactive compounds. Tenuazonic acid (21.6718%); Tetracosamethyl–cyclododecasiloxane (11.5408%); Bis (2˗ethylhexyl) phthalate (10.6541%); Cyclooctasiloxane, hexadecamethyl- (9.5733%); Cyclononasiloxane, octadecamethyl (8.2317%) are among the most important components. The following compounds are detected only in the A. alternata extract: Tenuazonic acid; Tetratetracontane; 8-Cinnamoyl-5,7-dihydroxy-2,2,6-trimethylchromene, 2TMS derivative; Octyl tetracosyl ether; tert-Hexadecanethiol; Hexadecane, 1-bromo-; Heptacosane; Terephthalic acid, bis (2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoroheptyl) ester; 4-Hydroxybenzyl alcohol, 2TBDMS derivative; 2-(5-Bromo-pyridin-2-ylamino)-3,3,3-trifluoro-2-(4-methoxy-benzoylamino)-propionic acid methyl ester; N-(2-Hydroxy-4-nitrophenyl)-4-methoxybenzamide, TMS derivative; Octadecane, 1-iodo-; Hexadecane; Bis(2-ethylhexyl) phthalate; [1,3]-Oxazino[5,6-c]quinoline,3-(3,4-methylenedioxybenzyl)-5-trifluoromethyl-3,4(2H)-dihydro-7-methoxy-; para-Isopropylbenzoic acid trimethylsilylester; Dodecane, 1-iodo-; 1,4-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester; Dodecane, 3-methyl-; Supraene; Phenol, 2-amino-4,6-bis (1,1-dimethylethyl)-; Benzene, 1,1,1-[1-(bromomethyl)-2-methoxy-1-methyl-1-ethanyl-2-ylidene]tris.
The extract of Z. lotus leaves contained 17 compounds, of which the maximum quantum was 1,1,1,5,7,7,7-Heptamethyl-3,3-bis (trimethylsiloxy) tetrasiloxane (17.5764%); followed by Cyclooctasiloxane, hexadecamethyl- (16.4283%). Among them, six compounds are also detected in the three fungal extracts (Cyclohexasiloxane, dodecamethyl-; Octasiloxane, 1,1,3,3,5,5,7,7,9,9,11,11,13,13,15,15-hexadecamethyl-; Tetracosamethyl-cyclododecasiloxane; Heptasiloxane, hexadecamethyl-; 1,1,1,5,7,7,7-Heptamethyl-3,3-bis(trimethylsiloxy)tetrasiloxane; and Cyclononasiloxane, octadecamethyl-). The compound Cyclooctasiloxane, hexadecamethyl-, is also detected in A. persii and A. altrnata extracts. 3,4-Dihydroxymandelic acid, 4TMS derivative, is also detected in A. cavernicola and A. persii extracts. The 3,4-Dihydroxyphenylglycol, 4TMS derivative; Heptasiloxane, 1,1,3,3,5,5,7,7,9,9,11,11,13,13-tetradecamethyl- are also detected in A. alternata extract. Hexanedioic acid, bis(2-ethylhexyl) ester is also detected in A. persii extract.

4. Discussion

Endophytic microorganisms living inside their host can often be cultured and grown after isolation from their host plants. In culture, outside of their host tissue, endophytic fungi are also known to produce a number of important secondary metabolites. Endophytic fungi are believed to imitate, duplicate, and modify the secondary metabolite compounds of their hosts, which is a complex process [27]. This represents a substantial biotechnological potential of endophytic fungi for the discovery of new drugs [28,29]. Thus, endophytic fungi can be used to isolate active metabolites and reduce the large-scale utilization of plants as a method to protect the environment [30]. Endophytic fungi are advantageous because they have short generation time, high biomass production due to high growth rates, and good handling features in bioreactors [31].
The in vitro antibacterial and antioxidant activities screening of ethyl acetate crude extracts of Z. lotus leaves and five endophytic fungi associated with the leaves of this same plant was performed in this study. Ethyl acetate extraction is the most efficient approach to isolating fungal secondary metabolites [32]. As an extraction solvent, ethyl acetate selectively extracts low-molecular-weight phenolic compounds and high-molecular-weight polyphenols [24,33]. Conde et al. (2008) [34] have reported that ethyl acetate allowed for the highest phenolic content and the selective removal of non-phenolic compounds.
Most studies have shown that endophytes were a good source of antibacterial agents [35]. Schulz et al. (2015) [36] suggested that to grow asymptomatically within their plant hosts, fungal endophytes would need to not only maintain a balanced antagonism with their plant host but also with other bacterial and fungal communities in the host. This would explain the synthesis of antibacterial and antifungal metabolites by fungal endophytes. Secondary metabolites are hypothesized to work as antibacterial substances in host plants and endophytic fungi by preventing cell wall development, modifying membrane permeability, inhibiting nucleic acid production, and decreasing the formation of essential metabolites in bacterial cells [37]. Among these substances, the phenolic compounds exhibit great structural diversity, such as the presence of hydroxyl groups, as well as their substitution position and saturated side-chain length, which confers antibacterial activity to these compounds [38,39].
In our study, the foliar extract of Z. lotus showed no inhibitory activity against Gram-positive and Gram-negative bacteria used in the tested concentration except for the two S. aureus. Yahia et al., 2020, [40] reported that the methanolic extract of Z. lotus leaves at a concentration of 10 mg/mL inhibited the growth of S. aureus, Listeria monocytogenes, Salmonella typhimurium, and E. coli, with inhibition zones ranging from 10 to 13 mm. Concerning the fungal extracts, we observed that all endophytic fungi extracts showed antibacterial activities against the strains S. aureus ATCC 25923, S. aureus MU50, E. faecalis WDCM00009, and E. coli ATCC 25922, whereas only A. cavernicola was able to inhibit the growth P. aeruginosa ATCC 27853. The fungal extracts were more effective on Gram-positive bacteria compared to Gram-negative bacteria. This may be due to the structural differences presented in the cellular walls of the two types of bacteria. Gram-negative bacteria have an outer polysaccharide membrane, which carries the structural lipopolysaccharide components. This makes the cell wall impermeable to lipophilic solutes. Gram-positive should be more susceptible, having only an outer peptidoglycan layer, which is not an effective permeability barrier [41,42].
Several studies have reported the antibacterial activity of extracts from fungal endophytes. Cladosporium spp. extracts reported by other works present antibacterial potential. The ethyl acetate extract of the endophytic Cladosporium ramotenellum isolated from Securinega suffruticosa exerted significant inhibitory effects on E. faecalis, E. coli, P. aeruginosa, and S. aureus [43].
The genus Fusarium was reported to produce diverse bioactive secondary metabolites with a broad spectrum of biological activities such as antibacterial [44], antifungal [45], and cytotoxic [46]. Tayung and Jha (2010) [47] reported that crude extracts obtained with ethyl acetate from a fermented broth of Fusarium sp. isolated from Taxus baccata showed significant antibacterial activity against S. aureus and E. coli, among others. Generally, F. incarnatum–equiseti complex strains are considered moderately virulent to many agricultural crops and produce a variety of mycotoxins, which represent a serious threat to food safety and public health [48]. Our study shows that F. incarnatum–equiseti complex can also function as an antibacterial agent. This result is of great significance for the development of new bio-control agents. Moreover, our results are in agreement with the study by Chatterjee et al. (2019) [37], which found that the ethyl acetate extract of endophytic fungus A. alternata VN3 isolated from Vitex negundo L. was effective against S. aureus and E. coli and not against P. aeruginosa. Abd Elghafar et al. (2022) [49] reported that the ethyl acetate crude extract of A. alternata from leaves of Ziziphus spina-christi exhibited promising antibacterial activity against Gram-negative bacteria (P. aeruginosa ATCC 27853, E. coli ATCC 11229, Proteus vulgaris RCMB 004, and Klebsiella pneumonia RCMB 003) and Gram-positive bacteria (S. aureus ATCC 25923, Bacillus subtilis RCMB 015, and Staphylococcus epidermidis ATCC 14990). Moreover, Kim et al. (2017) [50] reported that the fungus A. persii strain NIBRFGC000004109 showed strong antibacterial activity, especially against plant-pathogenic bacteria, including Agrobacterium tumefaciens, Ralstonia solanacearum, Xanthomonas arboricola pv. pruni, and Xanthomonas oryzae pv. oryzae. Furthermore, our study reports, for the first time, the antibacterial effect of extract from the endophytic A. cavernicola. Our results revealed that the ethyl acetate extract of A. cavernicola exhibited broad-spectrum activity in two different groups of bacteria. It was the only one able to inhibit the five tested bacteria.
In our study, extracts with antioxidant potential also had a good amount of total phenols as tested by Folin–Ciocalteu reagent-based assay. Previous studies conclude that there is a linear correlation between total phenolic content and the antioxidant potential of any sample [51]. Nuraini et al. (2019) [52] suggested that the phenolic contents in endophytic fungal culture extracts were the major antioxidant constituents. The low antioxidant capacity in the C. asperlatum and F. incarnatum–equiseti complex extracts observed in our results may be due to the low content of phenol. Phenolic compounds have hydroxyl groups and have been described for their antioxidant potential due to their ability to eliminate free radicals, high reducing power, and ability to inhibit lipid oxidation [39,53]. The ability of phenolic compounds to act as reducing agents, electron donors, oxygen quenchers, or metal chelators is mainly attributable to their redox characteristics [54]. Compared to the potency of the standard antioxidant ascorbic acid, the foliar and fungal extracts showed lower antioxidant activity, which could be justified by the fact that the antioxidant used as standard is an isolated molecule while the fungal and foliar extracts represent a set of substances at varied concentrations.
The results of this study link with some previous findings on endophytic fungi and their antioxidant activities.
Endophytic fungi have been reported as a good source of antioxidant metabolites [55]. Abd Elghafar et al., 2022, [49] isolated A. alternata from leaves of Z. spina-christi. Ethyl acetate crude extract of this A. alternata was assessed as an antioxidant using the DPPH method. Results revealed that the extract of A. alternata exhibited promising antioxidant activity compared to ascorbic acid, where activity at 500–2000 µg/mL was above 50%. In addition, results illustrated that IC50 of ethyl acetate crude extract of A. alternata was 409 µg/mL. In our study, the value is 535.67 µg/mL. The crude extract of A. alternata isolated from Coffea arabica L. showed an IC50 value of 86.7 μg/mL when tested by DPPH free radical scavenging assay [56]. Yadav et al., 2014, [24] isolated 21 endophytic fungi from Eugenia jambolana Lam, of which eight were Aspergillus (Aspergillus sp., Aspergillus peyronelii, Aspergillus niger, Aspergillus flavus, Aspergillus tubingensis, Aspergillus japonicus, Aspergillus terreus, Aspergillus niger strain, and Aspergillus aff. fumigatus). Ethyl acetate crude fungal extracts were explored for antioxidant potential by using three different methods. They all showed antioxidant activities up to varying extents. Aspergillus sp. showed a high antioxidant capacity, followed by A. peyronelii and A. niger.
The present study also shows that Z. lotus exerted an antioxidant activity. Our results agree well with the findings of Dhibi et al., 2022, [57], who have also observed that Z. lotus extracts exerted antioxidant effects.
Secondary metabolites from fungi are a plentiful and valuable source of molecules that exhibit a wide range of chemical structures and biological activities [6]. The GC–MS analysis of the ethyl acetate extracts revealed the presence of many compounds that might be involved in the above-described bioactivities.
Results of GC–MS analysis of all extracts analyzed by GC–MS revealed siloxane derivatives. In general, the compounds in the siloxane group are antibacterial [58,59]. For example, heptasiloxane, hexadecamethyl (detected in all analyzed extracts in this study) present in Egyptian red seaweed has antibacterial effect [60,61]. Cyclohexasiloxane, dodecamethyl- also detected in the profiles of extracts analyzed, has been reported as antimicrobial, antioxidant, antifungal, and emollient [61,62].
GC–MS analysis of ethyl acetate extract of A. cavernicola revealed butylphosphonic acid, 2-ethylhexyl propyl ester as a major compound with 37.468%. There is no activity reported about this compound specially, in the literature. But phosphonates were reported to be very useful in the therapeutic treatment due to the importance of the phosphonic substituents C-P(O)(OH)2, allowing for very remarkable flexibility for complexation with enzymes, on the one hand, and giving up the electrons or the hydrogen radicals through the process of electronic transfer attributed to this entity, on the other hand [63]. The second prevailing compound with 10.892% is 4-tert octylphenol, TMS derivative has no records of individual bioactivity. It was extracted from Euphorbia hirta leaf and is considered a novel bioactive compound [64]. The other compounds have a percentage of less than 10%. Moreover, a study by Sharma et al. (2009) [65] demonstrated the antimicrobial activities of imidazole derivatives against Gram-positive and Gram-negative bacteria, as well as fungi like Candida albicans. Other biological activities of imidazole and its derivatives included anti-inflammatory [66], anticancer [67], and antitubercular [68]. Hexadecanoic acid is one category of straight-chain saturated fatty acid commonly found in plants and animals. According to Pu et al. [69], hexadecanoic acid and its derivatives from neem oil could inhibit S. aureus, E. coli, and Salmonella sp. growth with MIC ranging from 20 to 0.625 mg/mL.
Many fungi have been reported to be producers of penicillic acid (2,5-Hexadienoic acid, 3-methoxy-5-methyl-4-oxo-), including the genus Penicillium and Aspergillus [70]. Since the penicillic acid was first isolated from the Penicillium puberulum [71], its various biological activities, such as antifungal, antitumor, antidiuretic, and various toxic activities, have been characterized [72,73]. In terms of antibacterial activity, penicillic acid is known to exert a strong inhibitory ability against Gram-positive and Gram-negative bacteria such as Bacillus cereus, Streptococcus pneumoniae, P. aeruginosa, and S. aureus [72].
Our study indicates, for the first time, the production of penicillic acid from A. cavernicola. A. persii is described as a member of section Circumdati with a strong production of penicillic acid [74]. In the work of Nguyen et al. (2016) [75], penicillic acid was isolated from Aspergillus persii EML-HPB1-11, and this compound effectively inhibited the growth of 12 plant pathogenic bacteria and successfully controlled bacterial spot disease on peach leaf. Obana et al.,1995, [76] reported the production of the polyketide 5,6-dihydropenicillic acid (DHPA) by various type strains of Aspergillus ochraceus and related strains of Aspergillus in nutrient cultures. This same study suggests that penicillic acid is produced on potato dextrose agar medium, but 5,6-dihydropenicillic acid is obtained under highly nutritious circumstances. It should be noted that both penicillic acid and 5,6-dihydropenicillic acid were obtained in our study following the cultivation of the A. cavernicola and A. persii in a potato dextrose broth. Imidazole derivatives possess antioxidant properties, expressed either by their capacity to scavenge free radicals or their ability to reduce lipid peroxidation [77].
Results of GC–MS analysis of ethyl acetate extract of A. persii revealed the furan 2,5-furandicarboxylic acid, tetrahydro-, dimethyl ester as a prevailing compound with (21.4686%). There is no activity reported about this compound in the literature. The second prevailing compound with (15.0705%) is the phosphinic acid, (1,1-dimethylethyl)[4-(1,1-dimethylethyl)phenyl]. Phosphinic acid compounds (phosphinates) are derivatives of phosphinic acid H2P(O)(OH) [78]. Phosphinic acid derivatives exhibit diverse biological activities (anti-inflammatory, anti-Alzheimer, antiparasitic, antihepatitis, antiproliferative, anti-influenza, anti-HIV, antimalarial, and antimicrobial) and a high degree of structural diversity, rendering them a versatile tool in the development of new medicinal agents [79]. The 2,5-hexadienoic acid, 3-methoxy-5-methyl-4-oxo- (penicillic acid) is the third prevailing (11.5193%); followed by l-Alanine, N-(3-fluorobenzoyl)-, heptyl ester (10.3966%). Other compounds detected in the ethyl acetate extract of Aspergillus persii were reported to have biological activity. For example, cyclopentane, 1-acetyl-1,2-epoxy- was reported to have anti-inflammatory, antiviral, and bronchodilatory properties [80,81]. Moon et al. (2010) [82] reported that Erythritol was a sweet antioxidant that released oxidative stress with unique nutritional properties. The study by Israa et al. (2017) [83] showed its anti-cariogenic effects. 3,4-Dihydroxymandelic acid, 4TMS derivative, was reported by Altameme et al. (2017) [84] as an antitumor, analgesic, and antimicrobial.
GC–MS analysis conducted on the crude ethyl acetate extract of A. alternata revealed tenuazonic acid (21.6718%); tetracosamethyl–cyclododecasiloxane (11.5408%); and bis (2˗ethylhexyl) phthalate (10.6541%) as major compounds. Tenuazonic acid has been used for the development of potential new drugs for the treatment of Alzheimer’s disease due to its acetylcholine esterase inhibitor and antioxidant properties, as well as its metal chelation capacity [85]. Tenuazonic acid produced by A. alternata showed a potential activity against Mycobacterium tuberculosis H37Rv [86]. Previous studies revealed that Tenuazonic acid is an efficient antibacterial, antiviral, and antitumor [87,88]. It is also qualified for its potential antifungal compounds, as described by Mousa et al., 2015, [89]. Tetracosamethyl-cyclododecasiloxane is reported as hepatoprotective, antispasmodic, and antirheumatic [90]. Our study reveals the production of the bis (2-ethylhexyl) phthalate by the genus Alternaria. It was found only in the subgenus Penicillium [91]. Bis-(2-ethylhexyl) phthalate (BEHP) has been reported as a potent bioactive secondary metabolite, naturally produced by bacterial, fungal, and algal species [92,93,94]. It has already been purified from the culture broth of a strain of actinomycetes Nocardia levis [95] and Streptomyces bangladeshensis [96]. These two studies indicate that the bis (2-ethylhexyl) phthalate exhibits antibacterial activity against bacterial strains S. aureus, E. coli, and P. Aeruginosa, among others. Recently, Bis-(2-ethylhexyl) phthalate (BEHP) was isolated from LAB species Lactiplanti-bacillus plantarum BCH-1, which showed significant larvicidal potential and antibacterial activity against E. coli and S. aureus [97]. The compound bis(2-ethylhexyl) phthalate, known as DEHP Di-(2-ethylhexyl) phthalate, was reported by Habib and Karim (2009) [98] to have antibacterial activity. Bis(2-ethylhexyl) phthalate is reported as an essential compound because of its biological properties as antioxidant, antiviral, and antitumor activity [93]. Our study reveals the production of 1,4-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester (other used names = di(2-ethylhexyl) terephthalate, dioctyl terephthalate, bis-2-ethylhexyl terephthalate). It should be noted that DEHT and DEHP are phthalic and terephthalic acid esters, the main plasticizers that are used to confer elasticity and flexibility to various fiber and plastic products [99]. Many studies have identified the presence of phthalate in medicinal plants, which most often exhibited antimicrobial activities [100]. Tetratetracontane is an alkane with antibacterial properties [101]. Tert-hexadecanthiol plays an important role in antibacterial and antioxidant activities [102,103]. Furthermore, in the study by Acar et al. 2020 [104], a series of N-(2-hydroxy-(4 or 5)-nitrophenyl) benzamide derivatives were designed and synthesized. According to this study, the newly synthesized benzamide derivatives mainly exhibited significant antibacterial activities. Quinoline motifs are known to be free radical scavengers [105].
GC–MS method showed that 1,1,1,5,7,7,7-Heptamethyl-3,3-bis(trimethylsiloxy) tetra-siloxane (17.5764%); Cyclooctasiloxane, hexadecamethyl- (16.4283%); 3,4-Dihydroxymandelic acid, 4TMS derivative (12.4779%); and Heptasiloxane, hexadecamethyl-(11.1441%) were the most dominant volatile components in the Z. lotus extract. An anti-quorum sensing potential is reported about 1,1,1,5,7,7,7-Heptamethyl-3,3-bis(trimethylsiloxy)tetrasiloxane [106]. Cyclooctasiloxane, hexadecamethyl- is reported as antimicrobial [90], and Heptasiloxane, hexadecamethyl- has antibacterial effect [61]. Cytochalasins H showed potential antibacterial and cytotoxic activities [107]. On the other hand, hexanedioic acid, bis (2-ethylhexyl) ester, has been reported as an antifungal [108,109].
Moreover, the antioxidant activities and antibacterial activity of extracts may be related to the chemical compounds previously identified. They could also be the result of other unidentified compounds contained in the non-volatile phase or a synergistic effect of several compounds.
Interestingly, certain compounds are found in both types of extract (the endophytic fungal extracts and the host plant leaves extract). Endophytes have adapted themselves to their special microenvironments by genetic variation, including the uptake of some plant DNA into their own genomes [110]. After long-term coexistence with their host, endophytes can synthesize biologically active substances similar to the secondary metabolites produced by host plants [111,112,113]. Recent findings revealed that endophytic fungi, not their host plants, synthesize certain molecules [114,115], highlighting these microorganisms’ crucial role in the discovery of novel pharmacologically active compounds.
Few metabolites reported by our study have already been described in the literature concerning plant and fungal species. That can be explained by the difference in the fermentation conditions, the solvent used for extraction, and the detection method used. In fact, one approach to the efficient production of secondary metabolites is represented by fermentation, a microorganism-driven process that enzymatically converts substrates into bioactive compounds [116]. The fungal secondary metabolite production is affected by various parameters. Fermentation [117] and culture conditions could be modulated to optimize the production of specific bioactive molecules [118]. Extrolites, these small molecules produced by fungi, are particularly sensitive to environmental and nutritional conditions [5,119,120]. Their biosynthesis may sometimes require activation by biological or chemical stimulants [120,121,122,123]. The extraction method also affects the diversity of recovered secondary metabolites, with ethyl acetate showing particular efficiency as an extraction solvent [32]. Finally, the detection method of secondary metabolites is also important. Volatile metabolites can be separated and detected by GC–MS, whereas most other secondary metabolites are extracted by organic solvents and separated and detected by HPLC-DAD-MS (high-performance liquid chromatography with diode array detection coupled with a Mass Spectrometer) [124]. Among the volatile compounds synthesized by endophytes, some are already known and identified in essential oils or other phytochemical products, while others represent new molecules for which no standards are yet available [125,126]. Fungal identification has recently evolved through new approaches integrating the analysis of secondary metabolite profiles, complementing morphological and genetic characteristics [127]. These new data significantly enrich our knowledge of the studied fungi, particularly regarding A. cavernicola. This species, belonging to the series and section Cavernicolarum, is considered synonymous with Aspergillus amylovorus [128]. The section Cavernicolarum remains poorly explored [129], as evidenced by the incomplete characterization of metabolites produced by this strain, of which only asperugin (a phenolic polyketide), red pigments related to monascorubramins, and some metabolites of the undetermined structure are currently identified [127].

5. Conclusions

In this study, the antibacterial and antioxidant activities of ethyl acetate extracts of leaves of Z. lotus and five endophytic fungi associated (C. asperulatum, A. cavernicola, A. persii, A. alternata, and F. incarnatum–equiseti complex) were revealed.
A. cavernicola demonstrated the most promising antibacterial activity, exhibiting broad-spectrum inhibition against both Gram-positive and Gram-negative bacteria, with particularly strong efficacy against Staphylococcus aureus (including the hospital-acquired MRSA strain), Enterococcus faecalis, and Escherichia coli. The antibacterial activity of A. cavernicola was not only significant in terms of inhibition zone sizes but also displayed low MIC values, indicating its strong antimicrobial potential.
The antioxidant potential was evaluated through DPPH and reducing power assays. A. cavernicola again showed the most potent antioxidant activity, suggesting it could serve as a valuable source of natural antioxidants. In contrast, other fungal species like C. asperulatum and F. incarnatum–equiseti complex showed limited or no antioxidant activity, indicating that not all endophytic fungi from Z. lotus possess significant antioxidant properties.
Additionally, the phenolic content analysis revealed that A. cavernicola contained the highest concentration of total phenolics, which likely contributes to both its antibacterial and antioxidant activities. The phenolic content in the A. cavernicola extract was nearly double that of Z. lotus leaves, suggesting a synergistic relationship between the host plant and its endophytic fungi in the biosynthesis of bioactive compounds.
The GC–MS analysis of the fungal extracts further confirmed the presence of a wide variety of bioactive compounds. Our study indicates, for the first time, the production of penicillic acid (2,5-Hexadienoic acid, 3-methoxy-5-methyl-4-oxo-) from A. cavernicola. Similarly, A. persii and A. alternata extracts contained unique compounds, some of which have been previously associated with antimicrobial and antioxidant properties, further supporting the potential of these fungi in drug discovery.
In summary, this study underscores the significant antimicrobial and antioxidant potential of endophytic fungi from Z. lotus, particularly A. cavernicola, which exhibit both broad-spectrum antibacterial activities and potent antioxidant properties. The diversity of bioactive compounds identified through GC–MS highlights the complex biochemical profiles of these fungal extracts, suggesting their promise as natural sources of therapeutic agents. Further research is needed to isolate and characterize these compounds in greater detail, as well as to evaluate their in vivo efficacy and safety, to fully exploit the potential of Z. lotus endophytic fungi for pharmaceutical and biotechnological applications.

Author Contributions

Conceptualization, A.G.-Y. and K.H.; methodology, A.G.-Y., N.S., K.H. and E.-h.N.; software, B.K. and J.H.; validation, K.H., C.C. and N.S., formal analysis, A.G.-Y., B.K., J.H. and E.-h.N.; investigation, A.G.-Y., N.S. and C.C.; resources, C.C. and K.H.; data curation, A.G.-Y., E.-h.N., C.C., N.S. and K.H.; writing—original draft preparation, A.G.-Y.; writing—review and editing, E.-h.N., C.C. and K.H.; visualization, E.-h.N. and K.H.; supervision, B.K., J.H., C.C. and K.H.; project administration, K.H. and E.-h.N.; funding acquisition, N.S. and K.H. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by (i) Portuguese funds from Fundação para a Ciência e a Tecnologia through the project UIDB/00329/2020 (DOI 10.54499/UIDB/00329/2020).

Data Availability Statement

The original contributions presented in this study are included in this article; further inquiries can be directed to the corresponding author.

Acknowledgments

The author would like to thank the Algerian Ministry of Higher Education for supporting this work.

Conflicts of Interest

The authors declare no conflicts of interest.

Correction Statement

This article has been republished with a minor correction to the Funding statement. This change does not affect the scientific content of the article.

References

  1. Amelia, P.; Ayunda, R.; Bahri, S. Screening of antibacterial activities of the endophytic fungi isolated from the leaves of Medinilla speciosa Blume. J. Fitofarmaka Indones. 2021, 8, 24–28. [Google Scholar] [CrossRef]
  2. Nisa, H.; Kamili, A.N.; Nawchoo, I.A.; Shafi, S.; Shameem, N.; Bandh, S.A. Fungal endophytes as prolific source of phytochemicals and other bioactive natural products: A review. Microb. Pathog. 2015, 82, 50–59. [Google Scholar] [CrossRef] [PubMed]
  3. Rodriguez, R.J.; White, J.F.J.; Arnold, A.E.; Redman, R.S. Fungal endophytes: Diversity and functional roles. N. Phytol. 2009, 182, 314–330. [Google Scholar] [CrossRef] [PubMed]
  4. Potshangbam, M.; Devi, S.I.; Sahoo, D.; Strobel, G.A. Functional characterization of endophytic fungal community associated with Oryza sativa L. and Zea mays L. Front. Microbiol. 2017, 8, 325. [Google Scholar] [CrossRef]
  5. Brakhage, A.A. Regulation of fungal secondary metabolism. Nat. Rev. Microbiol. 2013, 11, 21–32. [Google Scholar] [CrossRef]
  6. Perlatti, B.; Lan, N.; Jiang, Y.; An, Z.; Bills, G. Identification of secondary metabolites from Aspergillus pachycristatus by untargeted UPLC-ESI-HRMS/MS and genome mining. Molecules 2020, 25, 913. [Google Scholar] [CrossRef]
  7. Bhatia, D.R.; Dhar, P.; Mutalik, V.; Deshmukh, S.K.; Verekar, S.A.; Desai, D.C.; Kshirsagar, R.; Thiagarajan, P.; Agarwal, V. Anticancer activity of Ophiobolin A, isolated from the endophytic fungus Bipolaris setariae. Nat. Prod. Res. 2016, 30, 1455–1458. [Google Scholar] [CrossRef]
  8. Liu, X.; Wu, X.; Ma, Y.; Zhang, W.; Hu, L.; Feng, X.; Li, X.; Tang, X. Endophytic fungi from mangrove inhibit lung cancer cell growth and angiogenesis in vitro. Oncol. Rep. 2017, 37, 1793–1803. [Google Scholar] [CrossRef]
  9. Strobel, G.; Daisy, B.; Castillo, U.; Harper, J. Natural products from endophytic microorganisms. J. Nat. Prod. 2004, 67, 257–268. [Google Scholar] [CrossRef]
  10. Kumar, A.; Patil, D.; Rajamohanan, P.R.; Ahmad, A. Isolation, purification and characterization of vinblastine and vincristine from endophytic fungus Fusarium oxysporum isolated from Catharanthus roseus. PLoS ONE 2013, 8, e71805. [Google Scholar] [CrossRef]
  11. Li, Y.; Kumar, P.S.; Tan, Q.; Tan, X.; Yuan, M.; Luo, J.; He, M. Diversity and chemical fingerprinting of endo-metabolomes from endophytes associated with Ampelopsis grossedentata (Hand.-Mazz.) W. T. Wang possessing antibacterial activity against multidrug resistant bacterial pathogens. J. Infect. Public. Health 2021, 14, 1917–1926. [Google Scholar] [CrossRef] [PubMed]
  12. Gunasekaran, S.; Sathiavelu, M.; Arunachalam, S. In vitro antioxidant and antibacterial activity of endophytic fungi isolated from Mussaenda luteola. J. App. Pharm. Sci. 2017, 7, 234–238. [Google Scholar] [CrossRef]
  13. de Silva, D.D.; Rapior, S.; Sudarman, E.; Stadler, M.; Xu, J.; Alias, S.A.; Hyde, K.D. Bioactive metabolites from macrofungi: Ethnopharmacology, biological activities and chemistry. Fungal Divers 2013, 62, 1–40. [Google Scholar] [CrossRef]
  14. Wen, J.; Okyere, S.K.; Wang, J.; Huang, R.; Wang, Y.; Liu, L.; Nong, X.; Hu, Y. Endophytic fungi isolated from Ageratina adenophora exhibits potential antimicrobial activity against multidrug-resistant Staphylococcus aureus. Plants 2023, 12, 650. [Google Scholar] [CrossRef]
  15. Benammar, C.; Hichami, A.; Yessoufou, A.; Simonin, A.M.; Allali, H.; Khan, N. Zizyphus lotus L. (Desf.) modulates antioxidant activity and human T-cell proliferation. BMC Complement. Altern. Med. 2010, 10, 54. [Google Scholar] [CrossRef]
  16. Belmaghraoui, W.; El Madani, N.; Manni, A.; Harir, M.; Filali-Maltouf, A.; El Hajjaji, S.; El Fatni, O.K. Total phenolic and flavonoid content, antioxidant and antibacterial activity of Ziziphus lotus from morocco. Pharmacologyonline 2018, 3, 176–183. [Google Scholar]
  17. Lahlou, M.; El Mahi, M.; Hamamouchi, J. Evaluation des activités antifongique et molluscicide de Zizyphus lotus (L.) Desf. du Maroc Evaluation of antifungal and mollusuicidial activities of Moroccan Zizyphus lotus (L.) Desf. Ann. Pharm. Fr. 2002, 60, 410–414. [Google Scholar]
  18. Borgi, W.; Ghedira, K.; Chouchane, N. Antiinflammatory and analgesic activities of Zizyphus lotus root barks. Fitoterapia 2007, 78, 16–19. [Google Scholar] [CrossRef]
  19. Wahida, B.; Abderrahman, B.; Nabil, C. Antiulcerogenic activity of Zizyphus lotus (L.) extracts. J. Ethnopharmacol. 2007, 112, 228–231. [Google Scholar] [CrossRef]
  20. Ghazi-Yaker, A.; Kraak, B.; Houbraken, J.; Houali, K.; Saadoun, N. Diversity of Epiphytic and Endophytic Fungal Communities Associated with Leaves of Ziziphus lotus (L.) Lam. from Algeria. Pol. J. Ecol. 2023, 70, 159–174. [Google Scholar] [CrossRef]
  21. Lee, C.; Li, W.; Bang, S.; Lee, S.J.; Kang, N.-y.; Kim, S.; Kim, T.I.; Go, Y.; Shim, S.H. Secondary metabolites of the endophytic fungus Alternaria alternata JS0515 isolated from Vitex rotundifolia and their effects on pyruvate dehydrogenase activity. Molecules 2019, 24, 4450. [Google Scholar] [CrossRef] [PubMed]
  22. Pansanit, A.; Pripdeevech, P. Antibacterial secondary metabolites from an endophytic fungus, Arthrinium sp. MFLUCC16-1053 isolated from Zingiber cassumunar. Mycology 2018, 9, 264–272. [Google Scholar] [CrossRef] [PubMed]
  23. Ismaili, H.; Milella, L.; Fkih-Tetouani, S.; Ilidrissi, A.; Camporese, A.; Sosa, S.; Altinier, G.; Della, L.R.; Aquino, R. In vivo topical anti-inflammatory and in vitro antioxidant activities of two extracts of Thymus satureioides leaves. J. Ethnopharmacol. 2004, 91, 31–36. [Google Scholar] [CrossRef] [PubMed]
  24. Yadav, M.; Yadav, A.; Yadav, J.P. In vitro antioxidant activity and total phenolic content of endophytic fungi isolated from Eugenia jambolana Lam. Asian Pac. J. Trop. Med. 2014, 7, S256–S261. [Google Scholar] [CrossRef]
  25. Oyaizu, M. Studies on products of browning reaction antioxidative activities of products of browning reaction prepared from glucosamine. Jpn. J. Nutr. 1986, 44, 307–315. [Google Scholar] [CrossRef]
  26. Aligiannis, N.; Kalpoutzakis, E.; Mitaku, S.; Chinou, I.B. Composition and antimicrobial activity of the essential oils of two Origanum species. J. Agric. Food Chem. 2001, 49, 4168–4170. [Google Scholar] [CrossRef]
  27. Gouda, S.; Das, G.; Sen, S.K.; Shin, H.S.; Patra, J.K. Endophytes: A treasure house of bioactive compounds of medicinal importance. Front. Microbiol. 2016, 7, 1538. [Google Scholar] [CrossRef]
  28. Cruz, J.S.; da Silva, C.A.; Hamerski, L. Natural products from endophytic fungi associated with Rubiaceae Species. J. Fungi 2020, 6, 128. [Google Scholar] [CrossRef]
  29. El-hawary, S.S.; Moawad, A.S.; Bahr, H.S.; Abdelmohsen, U.R.; Mohammed, R. Natural product diversity from the endophytic fungi of the genus Aspergillus. RSC Adv. 2020, 10, 22058–22079. [Google Scholar] [CrossRef]
  30. Wu, C.; Wang, W.; Wang, X.; Shahid, H.; Yang, Y.; Wang, Y.; Wang, S.; Shan, T. Diversity and communities of culturable endophytic fungi from the root holoparasite Balanophora polyandra Griff. and their antibacterial and antioxidant activities. Ann. Microbiol. 2022, 72, 19. [Google Scholar] [CrossRef]
  31. Ludwig-Müller, J. Plants and endophytes: Equal partners in secondary metabolite production? Biotechnol. Lett. 2015, 37, 1325–1334. [Google Scholar] [CrossRef] [PubMed]
  32. Garcia, A.; Rhoden, S.A.; Bernardi-Wenzel, J.; Orlandelli, R.C.; Azevedo, J.L.; Pamphile, J.A. Antimicrobial activity of crude extracts of endophytic fungi isolated from medicinal plant Sapindus saponaria L. J. App. Pharm. Sci. 2012, 2, 035–040. [Google Scholar] [CrossRef]
  33. Scholz, E.; Rimpler, H. Proanthocyanidins from Krameria triandra root. Planta Med. 1989, 55, 379–384. [Google Scholar] [CrossRef] [PubMed]
  34. Conde, E.; Moure, A.; Domınguez, H.; Parajo, J.C. Fractionation of antioxidants from autohydrolysis of barley husks. J. Agric. Food Chem. 2008, 56, 10651–10659. [Google Scholar] [CrossRef]
  35. Katoch, M.; Singh, G.; Sharma, S.; Gupta, N.; Sangwan, P.L.; Saxena, A.K. Cytotoxic and antimicrobial activities of endophytic fungi isolated from Bacopa monnieri (L.) Pennell (Scrophulariaceae). BMC Complement. Altern. Med. 2014, 14, 52. [Google Scholar] [CrossRef]
  36. Schulz, B.; Hass, S.; Junker, C.; Andrée, N.; Schobert, M. Fungal endophytes are involved in multiple balanced antagonisms. Curr. Sci. 2015, 109, 39–45. Available online: https://www.jstor.org/stable/24905689 (accessed on 23 August 2024).
  37. Chatterjee, S.; Ghosh, R.; Mandal, N.C. Production of bioactive compounds with bactericidal and antioxidant potential by endophytic fungus Alternaria alternata AE1 isolated from Azadirachta indica A. Juss. PLoS ONE 2019, 14, e0214744. [Google Scholar] [CrossRef]
  38. Martelli, G.; Giacomini, D. Antibacterial and antioxidant activities for natural and synthetic dual-active compounds. Eur. J. Med. Chem. 2018, 158, 91–105. [Google Scholar] [CrossRef]
  39. Rocha, P.d.S.d.; Paula, V.M.B.; Olinto, S.C.F.; dos Santos, E.L.; de Picoli Souza, K.; Estevinho, L.M. Diversity, chemical constituents and biological activities of endophytic fungi isolated from Schinus terebinthifolius Raddi. Microorganisms 2020, 8, 859. [Google Scholar] [CrossRef]
  40. Yahia, Y.; Benabderrahim, M.A.; Tlili, N.; Bagues, M.; Nagaz, K. Bioactive compounds, antioxidant and antimicrobial activities of extracts from different plant parts of two Ziziphus Mill. species. PLoS ONE 2020, 15, e0232599. [Google Scholar] [CrossRef]
  41. Pandey, B.; Ghimire, P.; Agrawal, V.P. Studies on the antibacterial activity of the actinomycetes isolated from the Khumbu region of Nepal. J. Biol. Sci. 2004, 23, 44–53. [Google Scholar]
  42. Ogundare, A.O.; Adetuyi, F.C.; Akinyosoye, F.A. Antimicrobial activities of Vernonia tenoreana. Afr. J. Biotechnol. 2006, 5, 1663–1668. [Google Scholar]
  43. Du, W.; Yao, Z.; Li, J.; Sun, C.; Xia, J.; Wang, B.; Shi, D.; Ren, L. Diversity and antimicrobial activity of endophytic fungi isolated from Securinega suffruticosa in the Yellow River Delta. PLoS ONE 2020, 15, e0229589. [Google Scholar] [CrossRef] [PubMed]
  44. Zhang, X.Q.; Qu, H.R.; Bao, S.S.; Deng, Z.S.; Guo, Z.Y. Secondary metabolites from the endophytic fungus xylariales sp. and their antimicrobial activity. Chem. Nat. Compd. 2020, 56, 530–532. [Google Scholar] [CrossRef]
  45. Kobayashi, H.; Sunaga, R.; Furihata, K.; Morisaki, N.; Iwasaki, S. Isolation and structures of an antifungal antibiotic, fusarielin A, and related compounds produced by a Fusarium sp. J. Antibiot. 1995, 48, 42–52. [Google Scholar] [CrossRef]
  46. Kornsakulkarn, J.; Dolsophon, K.; Boonyuen, N.; Boonruangprapa, T.; Rachtawee, P.; Prabpai, S.; Kongsaeree, P.; Thongpanchang, C. Dihydronaphthalenones from endophytic fungus Fusarium sp. BCC14842. Tetrahedron 2011, 67, 7540–7547. [Google Scholar] [CrossRef]
  47. Tayung, K.; Jha, D.K. Antimicrobial endophytic fungal assemblages inhabiting bark of Taxus baccata L. of Indo-Burma mega biodiversity hotspot. Indian. J. Microbiol. 2010, 50 (Suppl. 1), 74–81. [Google Scholar] [CrossRef]
  48. Lu, Y.; Qiu, J.; Wang, S.; Xu, J.; Ma, G.; Shi, J.; Bao, Z. Species diversity and toxigenic potential of Fusarium incarnatum-equiseti Species Complex. Isolates from Rice and Soybean in China. Plant Dis. 2021, 105, 2628–2636. [Google Scholar] [CrossRef]
  49. Abd Elghafar, R.Y.; Amin, B.H.; Hashem, A.H.; Sehim, A.E. Promising endophytic Alternaria alternata from leaves of Ziziphus spina-christi: Phytochemical analyses, antimicrobial and antioxidant activities. Appl. Biochem. Biotechnol. 2022, 194, 3984–4001. [Google Scholar] [CrossRef]
  50. Kim, J.A.; Jeon, J.; Park, S.Y.; Kim, K.T.; Choi, G.; Nguyen, H.T.; Jeon, S.J.; Lee, H.B.; Bae, C.H.; Yang, H.S.; et al. Draft genome sequence of Aspergillus persii NIBRFGC000004109, which has antibacterial activity against plant-pathogenic bacteria. Genome Announc. 2017, 5, e00932-17. [Google Scholar] [CrossRef]
  51. Sultana, B.; Anwar, F.; Przybylski, R. Antioxidant activity of phenolic components present in barks of Azadirachta indica, Terminalia arjuna, and Eugenia jambolana Lam. trees. Food Chem. 2007, 104, 1106–1114. [Google Scholar] [CrossRef]
  52. Nuraini, F.R.; Setyaningsih, R.; Susilowati, A. Antioxidant activity of bioactive compound produced by endophytic fungi isolated from endemic plant of South Kalimantan Mangifera casturi Kosterm. In Proceedings of the International Conference on Biology and Applied Science, Malang, Indonesia, 13–14 March 2019. [Google Scholar] [CrossRef]
  53. Amorati, R.; Valgimigli, L. Modulation of the antioxidant activity of phenols by non-covalent interactions. Org. Biomol. Chem. 2012, 10, 4147–4158. [Google Scholar] [CrossRef] [PubMed]
  54. Al-Mansoub, M.A.; Asif, M.; Revadigar, V.; Hammad, M.A.; Chear, N.J.Y.; Hamdan, M.R.; Abdul Majid, A.; Asmawi, M.; Murugaiyah, V. Chemical composition, antiproliferative and antioxidant attributes of ethanolic extract of resinous sediment from Etlingera elatior (Jack.) inflorescence. Braz. J. Pharm. Sci. 2021, 57, e18954. [Google Scholar] [CrossRef]
  55. Khiralla, A.; Mohamed, I.; Thomas, J.; Mignard, B.; Spina, R.; Yagi, S.; Laurain-Mattar, D. A pilot study of antioxidant potential of endophytic fungi from some sudanese medicinal plants. Asian Pac. J. Trop. Med. 2015, 8, 701–704. [Google Scholar] [CrossRef]
  56. Fernandes, M.R.V.; Costa e Silva, T.A.; Pfenning, L.H.; da Costa-Neto, C.M.; Heinrich, T.A.; de Alencar, S.M.; de Lima, M.A.; IkegakiI, M. Biological activities of the fermentation extract of the endophytic fungus Alternaria alternata isolated from Coffea arabica L. Braz. J. Pharm. Sci. 2009, 45, 677–685. [Google Scholar] [CrossRef]
  57. Dhibi, M.; Amri, Z.; Bhouri, A.; Hammami, S.; Hammami, M. Comparative study of the phenolic profile and antioxidant activities of moringa (Moringa oleifera Lam.) and jujube (Ziziphus lotus Linn.) leaf extracts and their protective effects in frying stability of corn oil. Meas. Food 2022, 7, 100045. [Google Scholar] [CrossRef]
  58. Sauvet, G.; Fortuniak, W.; Kazmierski, K.; Chojnowski, J. Amphiphilic block and statistical siloxane copolymers with antimicrobial activity. J. Polym. Sci., Part. A Polym. Chem. 2003, 41, 2939–2948. [Google Scholar] [CrossRef]
  59. Liang, J.; Barnes, K.; Akdag, A.; Worley, S.D.; Lee, J.; Broughton, R.M.; Huang, T.S. Improved antimicrobial siloxane. Ind. Eng. 2007, 46, 1861–1866. [Google Scholar] [CrossRef]
  60. Mohy El-Din, S.M.; El-Ahwany, A.M.D. Bioactivity and phytochemical constituents of marine red seaweeds (Jania rubens, Corallina mediterranea and Pterocladia capillacea). J. Taibah Univ. Sci. 2016, 10, 471–484. [Google Scholar] [CrossRef]
  61. Hai, N.T.; Diep, C.N. Bioactive secondary metabolites from marine Streptomyces isolated from mangrove forest soil of Can Gio, HoChiMinh City, Vietnam. Int. J. Pharm. Clin. Res. 2022, 14, 07–15. [Google Scholar]
  62. Rahamouz-Haghighi, S.; Bagheri, K.; Mohsen-Pour, N.; Sharafi, A. In vitro evaluation of cytotoxicity and antibacterial activities of ribwort plantain (Plantago lanceolata L.) root fractions and phytochemical analysis by Gas Chromatography-Mass Spectrometry. Arch. Razi Inst. 2022, 77, 2131–2143. [Google Scholar] [PubMed]
  63. Houas, N.; Kitouni, S.; Chafai, N.; Ghedjati, S.; Djenane, M.; Tounsi, A. New bi-phosphonate derivative: Synthesis, characterization, antioxidant activity in vitro and via cyclic voltammetry mode and evaluation of its inhibition of SARS-CoV-2 main protease. J. Mol. Struct. 2023, 1284, 135356. [Google Scholar] [CrossRef] [PubMed]
  64. De, M.; Sharma, L.; Acharya, C.K.A.A. Comprehensive chemical characterization of leaves of five potential medicinal plants in Paschim Medinipur District, W.B., India. Int. J. Exp. Res. Rev. 2023, 36, 20–36. [Google Scholar] [CrossRef]
  65. Sharma, D.; Narasimhan, B.; Kumar, P.; Judge, V.; Narang, R.; De Clercq, E.; Balzarini, J. Synthesis, antimicrobial and antiviral evaluation of substituted imidazole derivatives. Eur. J. Med. Chem. 2009, 44, 2347–2353. [Google Scholar] [CrossRef]
  66. Singh, D.; Kharb, R.; Sharma, S.K. Schiff’s base imidazole derivatives synthesis and evaluation for their anti-inflammatory activity. Orient. J. Chem. 2024, 40, 152–164. [Google Scholar] [CrossRef]
  67. Ali, I.; Lone, M.N.; Aboul-Enein, H.Y. Imidazoles as potential anticancer agents. Med. Chem. Comm. 2017, 8, 1742–1773. [Google Scholar] [CrossRef]
  68. Pandey, J.; Tiwari, V.K.; Verma, S.S.; Chaturvedi, V.; Bhatnagar, S.; Sinha, S.; Gaikwad, A.N.; Tripathi, R.P. Synthesis and antitubercular screening of imidazole derivatives. Eur. J. Med. Chem. 2009, 44, 3350–3355. [Google Scholar] [CrossRef]
  69. Pu, Z.H.; Zhong, Y.Q.; Yin, Z.Q. Antibacterial activity of 9-octadecanoic acid hexadecanoic acid-Tetrahydrofuran-3,4-diylester from Neem oil. Agr. Sci. China 2010, 9, 1236–1240. [Google Scholar] [CrossRef]
  70. Ismaiel, A.A.; Papenbrock, J. Mycotoxins: Producing Fungi and Mechanisms of Phytotoxicity. Agriculture 2015, 5, 492–537. [Google Scholar] [CrossRef]
  71. Alsberg, C.; Black, O.F. Contributions to the Study of Maize Deterioration: Biochemical and Toxicological Investigations of Penicillium puberulum and Penicillium stoloniferum; U.S. Government Publishing Office: Washington, DC, USA, 1913; p. 47.
  72. Ezzat, S.M.; El-Sayed, E.A.; Abou El-Hawa, M.I.; Ismaiel, A.A. Morphological and ultrastructural studies for the biological action of penicillic acid on some bacterial species. Res. J. Microbiol. 2007, 2, 303–314. Available online: https://scialert.net/abstract/?doi=jm.2007.303.314 (accessed on 29 April 2024).
  73. Kang, S.W.; Kim, S.W. New antifungal activity of penicillic acid against Phytophthora species. Biotechnol. Lett. 2004, 26, 695–698. [Google Scholar] [CrossRef] [PubMed]
  74. Visagie, C.M.; Varga, J.; Houbraken, J.; Meijer, M.; Kocsubé, S.; Yilmaz, N.; Fotedar, R.; Seifert, K.A.; Frisvad, J.C.; Samson, R.A. Ochratoxin production and taxonomy of the yellow aspergilli (Aspergillus section Circumdati). Stud. Mycol. 2014, 78, 1–61. [Google Scholar] [CrossRef] [PubMed]
  75. Nguyen, H.T.; Yu, N.H.; Jeon, S.J.; Lee, H.W.; Bae, C.H.; Yeo, J.H.; Lee, H.B.; Kim, I.S.; Park, H.W.; Kim, J.C. Antibacterial activities of penicillic acid isolated from Aspergillus persii against various plant pathogenic bacteria. Lett. Appl. Microbiol. 2016, 62, 488–493. [Google Scholar] [CrossRef] [PubMed]
  76. Obana, H.; Kumeda, Y.; Nishimune, T. Aspergillus ochraceus Production of 5,6-Dihydropenicillic Acid in Culture and Foods. J. Food Prot. 1995, 58, 519–523. [Google Scholar] [CrossRef]
  77. Sorrenti, V.; Salerno, L.; Di Giacomo, C.; Acquaviva, R.; Siracusa, M.A.; Vanella, A. Imidazole derivatives as antioxidants and selective inhibitors of nNOS. Nitric Oxide 2006, 14, 45–50. [Google Scholar] [CrossRef]
  78. Collinsová, M.; Jirácek, J. Phosphinic acid compounds in biochemistry, biology and medicine. Curr. Med. Chem. 2000, 7, 629–647. [Google Scholar] [CrossRef]
  79. Abdou, M.M.; O’Neill, P.M.; Amigues, E.; Matziari, M. Phosphinic acids: Current status and potential for drug discovery. Drug Discov. Today 2019, 24, 916–929. [Google Scholar] [CrossRef]
  80. Awakan, O.J.; Malomo, S.O.; Adejare, A.A.; Igunnu, A.; Atolani, O.; Adebayo, A.H.; Owoyele, B.V. Anti-inflammatory and bronchodilatory constituents of leaf extracts of Anacardium occidentale L. in animal models. J. Integr. Med. 2018, 16, 62–70. [Google Scholar] [CrossRef]
  81. Padmashree, M.S.; Ashwathanarayana, R.; Raja, N.; Roopa, B. Antioxidant, cytotoxic and nutritive properties of Ipomoea staphylina Roem & Schult. plant extracts with preliminary phytochemical and GCMS analysis. Asian J. Pharm. Pharmacol. 2018, 4, 473–492. [Google Scholar]
  82. Moon, H.-J.; Jeya, M.; Kim, I.-W.; Lee, J.-K. Biotechnological production of erythritol and its applications. Appl. Microbiol. Biotechnol. 2010, 86, 1017–1025. [Google Scholar] [CrossRef]
  83. Israa, A.; Mohammed, H.; Imad, H. Analysis of Bioactive Compounds of Methanolic Leaves extract of Mentha pulegium Using Gas Chromatography-Mass Spectrometry (GC-MS) Technique. Int. J. Pharm. Qual. Assur. 2017, 8, 174–182. [Google Scholar] [CrossRef]
  84. Altameme, H.J.; Hameed, I.H.; Hamza, L.F. Anethum graveolens: Physicochemical properties, medicinal uses, antimicrobial effects, antioxidant effect, antiinflammatory and analgesic effects: A review. Int. J. Pharm. Qual. Assur. 2017, 8, 88–91. [Google Scholar] [CrossRef]
  85. Piemontese, L.; Vitucci, G.; Catto, M.; Laghezza, A.; Perna, F.M.; Rullo, M.; Loiodice, F.; Capriati, V.; Solfrizzo, M. Natural scaffolds with multi-target activity for the potential treatment of Alzheimer’s disease. Molecules 2018, 23, 2182. [Google Scholar] [CrossRef] [PubMed]
  86. Lou, J.; Fu, L.; Peng, Y.; Zhou, L. Metabolites from Alternaria Fungi and Their Bioactivities. Molecules 2013, 18, 5891–5935. [Google Scholar] [CrossRef]
  87. Miller, F.; Rightsel, W.; Sloan, B.; Ehrlich, J.; French, J.; Bartz, Q.; Dixon, G.J. Antiviral Activity of Tenuazonic Acid. Nature 1963, 200, 1338–1339. [Google Scholar] [CrossRef]
  88. Gitterman, C.O. Antitumor, cytotoxic, and antibacterial activities of tenuazonic acid and congeneric tetramic acids. J. Med. Chem. 1965, 8, 483–486. [Google Scholar] [CrossRef]
  89. Mousa, W.K.; Schwan, A.; Davidson, J.; Strange, P.; Liu, H.; Zhou, T.; Auzanneau, F.-I.; Raizada, M.N. An endophytic fungus isolated from finger millet (Eleusine coracana) produces anti-fungal natural products. Front. Microbiol. 2015, 6, 1157. [Google Scholar] [CrossRef]
  90. Al Bratty, M.; Makeen, H.A.; Alhazmi, H.A.; Syame, S.M.; Abdalla, A.N.; Homeida, H.E.; Sultana, S.; Ahsan, W.; Khalid, A. Phytochemical, cytotoxic, and antimicrobial evaluation of the fruits of miswak plant, Salvadora persica L. J. Chem. 2020, 2020, 4521951. [Google Scholar] [CrossRef]
  91. Frisvad, J.C.; Smedsgaard, J.; Larsen, T.O.; Samson, R.A. Mycotoxins, drugs and other extrolites produced by species in Penicillium subgenus Penicillium. Stud. Mycol. 2004, 49, 201–242. [Google Scholar]
  92. Chen, C.Y. Biosynthesis of di-(2-ethylhexyl) phthalate (DEHP) and di-n-butyl phthalate (DBP) from red alga—Bangia atropurpurea. Water Res. 2004, 38, 1014–1018. [Google Scholar] [CrossRef]
  93. El-Sayed, O.H.; Asker, M.; Shash, S.M.; Hamed, S.R. Isolation, structure elucidation and biological activity of Di-(2-ethylhexyl) phthalate produced by Penicillium janthinellum 62. Int. J. Chemtech Res. 2015, 8, 58–66. [Google Scholar]
  94. Kalinovskaya, N.I.; Romanenko, L.A.; Kalinovsky, A.I. Antibacterial low-molecular-weight compounds produced by the marine bacterium Rheinheimera japonica KMM 9513 T. Antonie Leeuwenhoek 2017, 110, 719–726. [Google Scholar] [CrossRef] [PubMed]
  95. Kavitha, A.; Prabhakar, P.; Vijayalakshmi, M.; Venkateswarlu, Y. Production of bioactive metabolites by Nocardia levis MK-VL_113. Lett. Appl. Microbiol. 2009, 49, 484–490. [Google Scholar] [CrossRef] [PubMed]
  96. Al-Bari, M.A.A.; Sayeed, M.A.; Rahman, M.S.; Mossadik, M.A. Characterization and antimicrobial activities of a phthalic acid derivative produced by Streptomyces bangladeshiensis, a novel species collected in Bangladesh. Res. J. Med. Med. Sci. 2006, 1, 77–81. [Google Scholar]
  97. Javed, M.R.; Salman, M.; Tariq, A.; Tawab, A.; Zahoor, M.K.; Naheed, S.; Shahid, M.; Ijaz, A.; Ali, H. The antibacterial and larvicidal potential of Bis-(2-Ethylhexyl) Phthalate from Lactiplantibacillus plantarum. Molecules 2022, 27, 7220. [Google Scholar] [CrossRef]
  98. Habib, M.R.; Karim, M.R. Antimicrobial and cytotoxic activity of Di-(2-ethylhexyl) Phthalate and Anhydrosophoradiol-3-acetate isolated from Calotropis gigantea (Linn.) Flower. Mycobiology 2009, 37, 31–36. [Google Scholar] [CrossRef]
  99. Kdimy, A.; Kim, S.J.; Ali, Z.; Khan, M.I.H.; Tripathi, S.K.; El Hajjaji, S.; Le, H.V. Isolation of two plasticizers, Bis(2-ethylhexyl) Terephthalate and Bis(2-ethylhexyl) Phthalate, from Capparis spinosa L. leaves. Chem. Biodivers. 2023, 20, e202300903. [Google Scholar] [CrossRef]
  100. Rahmayanti, F.; Suniarti, D.F.; Masud, Z.A.; Wimardhani, Y.S.; Subita, G.P. Phytochemical compounds of Garcinia Mangostana-Linn Pericarp fractions from ethanolic extract. J. Int. Dent. Med. Res. 2017, 10, 48–51. [Google Scholar]
  101. Gumgumjee, N.M.; Hajar, A.S. Antibacterial activities and GC-MS analysis of phytocomponents of Ehretia abyssinica R. Br. ex Fresen. Int. J. Appl. Biol. Pharm. 2015, 6, 236–241. [Google Scholar]
  102. Sivakumar, S.R. GC-MS analysis and antibacterial potential of white crystalline solid from red algae Portieria hornemannii against the plant pathogenic bacteria Xanthomnas axonopodis pv. citri (Hasse) Vauterin et al. and Xanthomonas campestris pv. Malvacearum. Int. J. Adv. Res. 2014, 2, 174–183. [Google Scholar]
  103. Qanash, H.; Yahya, R.; Bakri, M.M.; Bazaid, A.S.; Qanash, S.; Shater, A.F.; Abdelghany, T.M. Anticancer, antioxidant, antiviral and antimicrobial activities of Kei Apple (Dovyalis caffra) fruit. Sci. Rep. 2022, 12, 5914. [Google Scholar] [CrossRef] [PubMed]
  104. Acar, C.; Yalçın, G.; Ertan-Bolelli, T.; Kaynak, O.F.; Ökten, S.; Şener, F.; Yıldız, İ. Synthesis and molecular docking studies of some novel antimicrobial benzamides. Bioorg. Chem. 2020, 94, 103368. [Google Scholar] [CrossRef] [PubMed]
  105. Puskullu, M.O.; Shirinzadeh, H.; Nenni, M.; Gurer-Orhan, H.; Suzen, S. Synthesis and evaluation of antioxidant activity of new quinoline-2-carbaldehydehydrazone derivatives: Bioisosteric melatonin analogues. J. Enzym. Inhib. Med. Chem. 2015, 31, 121–125. [Google Scholar] [CrossRef] [PubMed]
  106. Musthafa, K.S.; Sahu, S.K.; Ravi, A.V.; Kathiresan, K. Anti-quorum sensing potential of the mangrove Rhizophora annamalayana. World J. Microbiol. Biotechnol. 2013, 29, 1851–1858. [Google Scholar] [CrossRef]
  107. Jouda, J.B.; Tamokou, J.; Mbazoa, C.D.; Douala-Meli, C.; Sarkar, P.; Bag, P.K.; Wandji, J. Antibacterial and cytotoxic cytochalasins from the endophytic fungus Phomopsis sp. harbored in garcinia kola (heckel) nut. BMC Complement. Altern. Med. 2016, 16, 462. [Google Scholar] [CrossRef]
  108. Elleuch, L.; Shaaban, M.; Smaoui, S.; Mellouli, L.; Karray-Rebai, I.; Fguira, L.F.B.; Shaaban, K.A.; Laatsch, H. Bioactive secondary metabolites from a new terrestrial Streptomyces sp. TN262. Appl. Biochem. Biotechnol. 2010, 162, 579–593. [Google Scholar] [CrossRef]
  109. Xue-Na, B.; Cheng, J.; Liang, W.; LanQing, M.; Yu-Bo, L.; Guang-Lu, S.; You-Nian, W. Antifungal activity of extracts by supercritical carbon dioxide extraction from roots of Stellera chamaejasme L. and analysis of their constituents using GC-MS. In Advances in Intelligent and Soft Computing; Zhu, E., Sambath, S., Eds.; Springer: Berlin/Heidelberg, Germany, 2012; Volume 134, pp. 653–662. [Google Scholar] [CrossRef]
  110. Germaine, K.; Keogh, E.; Garcia-Cabellos, G.; Borremans, B.; Van Der Lelie, D.; Barac, T.; Oeyen, L.; Vangronsveld, J.; Moore, F.P.; Moore, E.R.; et al. Colonisation of poplar trees by gfp expressing bacterial endophytes. FEMS Microbiol. Ecol. 2004, 48, 109–118. [Google Scholar] [CrossRef]
  111. Strobel, G.; Daisy, B. Bioprospecting for Microbial Endophytes and Their Natural Products. Microbiol. Mol. Biol. Rev. 2003, 67, 491–502. [Google Scholar] [CrossRef]
  112. Wang, Y.; Dai, C.-C. Endophytes: A potential resource for biosynthesis, biotransformation, and biodegradation. Ann. Microbiol. 2011, 61, 207–215. [Google Scholar] [CrossRef]
  113. Guo, B.; Wang, Y.; Sun, X.; Tang, K. Bioactive natural products from endophytes: A review. Appl. Biochem. Microbiol. 2008, 44, 136–142. [Google Scholar] [CrossRef]
  114. Strobel, G.A.; Hess, W.M.; Ford, E.; Sidhu, R.S.; Yang, X. Taxol from fungal endophytes and the issue of biodiversity. J. Ind. Microbiol. Biotechnol. 1996, 17, 417–423. [Google Scholar] [CrossRef]
  115. Wang, J.; Li, G.; Lu, H.; Zheng, Z.; Huang, Y.; Su, W. Taxol from Tubercularia sp. strain TF5, an endophytic fungus of Taxus mairei. FEMS Microbiol. Lett. 2000, 193, 249–253. [Google Scholar] [CrossRef] [PubMed]
  116. Parvez, S.; Malik, K.A.; Ah Kang, S.; Kim, H.Y. Probiotics and their fermented food products are beneficial for health. J. Appl. Microbiol. 2006, 100, 1171–1185. [Google Scholar] [CrossRef] [PubMed]
  117. Miao, L.; Kwong, T.N.; Qian, P.Y. Effect of culture conditions on mycelial growth, antibacterial activity, and metabolite profiles of the marine-derived fungus Arthrinium saccharicola. Appl. Microbiol. Biotechnol. 2006, 72, 1063–1073. [Google Scholar] [CrossRef] [PubMed]
  118. Pu, X.; Qu, X.; Chen, F.; Bao, J.; Zhang, G.; Luo, Y. Camptothecin-producing endophytic fungus Trichoderma atroviride LY357: Isolation, identification, and fermentation conditions optimization for camptothecin production. Appl. Microbiol. Biotechnol. 2013, 97, 9365–9375. [Google Scholar] [CrossRef]
  119. Nielsen, M.L.; Nielsen, J.B.; Rank, C.; Klejnstrup, M.L.; Holm, D.M.K.; Brogaard, K.H.; Hansen, B.G.; Frisvad, J.C.; Larsen, T.O.; Mortensen, U.H. A genome-wide polyketide synthase deletion library uncovers novel genetic links to polyketides and meroterpenoids in Aspergillus nidulans. FEMS Microbiol. Lett. 2011, 321, 157–166. [Google Scholar] [CrossRef]
  120. Frisvad, J.C.; Larsen, T.O. Extrolites of Aspergillus fumigatus and Other Pathogenic Species in Aspergillus Section Fumigati. Front. Microbiol. 2016, 6, 1485. [Google Scholar] [CrossRef]
  121. Brakhage, A.A.; Schroeckh, V. Fungal secondary metabolites—Strategies to activate silent gene clusters. Fungal Genet. Biol. 2011, 48, 15–22. [Google Scholar] [CrossRef]
  122. Zuck, K.M.; Shipley, S.; Newman, D.J. Induced production of N-formyl alkaloids from Aspergillus fumigatus by co-culture with Streptomyces peucetius. J. Nat. Prod. 2011, 74, 1653–1657. [Google Scholar] [CrossRef]
  123. Netzker, T.; Fischer, J.; Weber, J.; Mattem, D.J.; Konig, C.C.; Valiante, V.; Schroeckh, V.; Brakhage, A.A. Microbial communication lading to the activation of silent fungal secondary metabolite gene clusters. Front. Microbiol. 2015, 6, 299. [Google Scholar] [CrossRef]
  124. Frisvad, J.C.; Larsen, T.O.; de Vries, R.; Meijer, M.; Houbraken, J.; Cabañes, F.J.; Ehrlich, K.; Samson, R.A. Secondary metabolite profiling, growth profiles and other tools for species recognition and important Aspergillus mycotoxins. Stud. Mycol. 2007, 59, 31–37. [Google Scholar] [CrossRef] [PubMed]
  125. Sharifi-Rad, J.; Sureda, A.; Tenore, G.C.; Daglia, M.; Sharifi-Rad, M.; Valussi, M.; Tundis, R.; Loizzo, M.R.; Ademiluyi, A.O.; Sharifi-Rad, R.; et al. Biological activities of essential oils: From plant chemoecology to traditional healing systems. Molecules 2017, 22, 70. [Google Scholar] [CrossRef] [PubMed]
  126. Andrade, M.; Ribeiro-Santos, R.; Sanches Silva, A. Essential oils from plants: Industrial applications and biotechnological production. In Exploring Plant Cells for the Production of Compounds of Interest; Malik, S., Ed.; Springer: Cham, Switzerland, 2021; pp. 145–170. [Google Scholar] [CrossRef]
  127. Samson, R.A.; Varga, J.; Meijer, M.; Frisvad, J.C. New taxa in Aspergillus section Usti. Stud. Mycol. 2011, 69, 81–97. [Google Scholar] [CrossRef] [PubMed]
  128. Chen, A.J.; Frisvad, J.C.; Sun, B.D.; Varga, J.; Kocsubé, S.; Dijksterhuis, J.; Kim, D.H.; Hong, S.-B.; Houbraken, J.; Samson, R.A. Aspergillus section Nidulantes (formerly Emericella): Polyphasic taxonomy, chemistry and biology. Stud. Mycol. 2016, 84, 1–118. [Google Scholar] [CrossRef]
  129. Sun, B.D.; Houbraken, J.; Frisvad, J.C.; Jiang, X.Z.; Chen, A.J.; Samson, R.A. New species in Aspergillus section Usti and an overview of Aspergillus section Cavernicolarum. Int. J. Syst. Evol. Microbiol. 2020, 70, 5401–5416. [Google Scholar] [CrossRef]
Figure 1. Antibacterial activity of ethyl acetate extracts (A) S. aureus ATCC 25923, (B) S. aureus MU50, (C) E. faecalis WDCM00009 (D) E. coli ATCC 25922, and (E) P. aerugenosa ATCC 27853 (F.iec: Fusarium incarnatum–equiseti complex; A.c: Aspergillus cavernicola; A.p: Aspergillus persii; C.a: Cladosporium asperlatum; A.a: Alternaria alternata; Z.l: Ziziphus lotus; DMSO: Dimethylsulfoxide; AT: antibiotic Chloramphenicol).
Figure 1. Antibacterial activity of ethyl acetate extracts (A) S. aureus ATCC 25923, (B) S. aureus MU50, (C) E. faecalis WDCM00009 (D) E. coli ATCC 25922, and (E) P. aerugenosa ATCC 27853 (F.iec: Fusarium incarnatum–equiseti complex; A.c: Aspergillus cavernicola; A.p: Aspergillus persii; C.a: Cladosporium asperlatum; A.a: Alternaria alternata; Z.l: Ziziphus lotus; DMSO: Dimethylsulfoxide; AT: antibiotic Chloramphenicol).
Microorganisms 12 02671 g001
Figure 2. DPPH radical scavenging activities of endophytic fungi and Z. lotus leaves ethyl acetate extracts in comparison with ascorbic acid.
Figure 2. DPPH radical scavenging activities of endophytic fungi and Z. lotus leaves ethyl acetate extracts in comparison with ascorbic acid.
Microorganisms 12 02671 g002
Figure 3. Reducing power activity of samples and ascorbic acid at 1 mg/mL.
Figure 3. Reducing power activity of samples and ascorbic acid at 1 mg/mL.
Microorganisms 12 02671 g003
Figure 4. Total phenolic contents in Z. lotus and its endophytic fungi.
Figure 4. Total phenolic contents in Z. lotus and its endophytic fungi.
Microorganisms 12 02671 g004
Table 1. Bacterial growth inhibition: Measuring effectiveness of leaf and fungal extracts.
Table 1. Bacterial growth inhibition: Measuring effectiveness of leaf and fungal extracts.
ExtractsInhibition Zones (mm ± ET) Corresponding to Each Bacteria
Staphylococcus aureus ATCC 25923Staphylococcus aureus MU50Enterococcus faecalis
WDCM00009
Escherichia coli ATCC 25922Pseudomonas aeruginosa
ATCC 27853
ATCC 27853
Ziziphus lotus8 ± 008 ± 0000 ± 0000 ± 0000 ± 00
Fusarium incarnatum–equiseti complex20 ± 0020 ± 0020 ± 0015 ± 100 ± 00
Aspergillus cavernicola32 ± 0031.33 ± 1.1530 ± 0025 ± 009 ± 00
Aspergillus persii27 ± 127 ± 126 ± 0017.33 ± 200 ± 00
Cladosporium asperlatum23.33 ± 1.1521.66 ± 1.5224 ± 0021 ± 200 ± 00
Alternaria alternata27 ± 127 ± 125 ± 124.66 ± 1200 ± 00
DMSO00 ± 0000 ± 0000 ± 0000 ± 0000 ± 00
Chloramphenicol35.66 ± 4.6131 ± 125 ± 0025 ± 0012 ± 1
Table 2. MIC and MBC of the five endophytic fungi crude extracts against tested pathogenic bacteria.
Table 2. MIC and MBC of the five endophytic fungi crude extracts against tested pathogenic bacteria.
ExtractsStaphylococcus aureus ATCC 25923Staphylococcus aureus MU50Enterococcus faecalis
WDCM00009
Escherichia coli ATCC 25922Pseudomonas aeruginosa
ATCC 27853
MICMBCMICMBCMICMBCMICMBCMICMBC
Fusarium incarnatum–equiseti complex1.25>51.25>51.25>50.625>5--
Aspergillus cavernicola0.0781.250.3121.250.0781.250.07850.6252.5
Aspergillus persii0.31251.25>50.0782.50.3122.5--
Cladosporium asperlatum1.2552.5>55>50.3125--
Alternaria alternata0.31250.3122.50.6252.50.625>5--
Table 3. Compounds identified by GC–MS analysis.
Table 3. Compounds identified by GC–MS analysis.
Compound NameArea Percent
Z. lotusA. CavernicolaA. PersiiA.
Alternata
1Compounds found in the four extracts analyzed
5.7404

0.9913

0.907

4.7928
Cyclohexasiloxane, dodecamethyl-
2Octasiloxane, 1,1,3,3,5,5,7,7,9,9,11,11,13,13,15,15-hexadeca methyl-4.76062.50010.67816.7681
3Tetracosamethyl-cyclododecasiloxane8.22172.49542.819311.5408
4Heptasiloxane, hexadecamethyl-11.14412.17584.49510.876
51,1,1,5,7,7,7-Heptamethyl-3,3-bis(trimethylsiloxy)tetrasiloxane17.57642.85545.05157.376
6Cyclononasiloxane, octadecamethyl-2.08310.72892.03138.2317

7
Compounds found in only three extracts
12.4779

1.0161

1.1417

-
3,4-Dihydroxymandelic acid, 4TMS derivative
8Cyclooctasiloxane, hexadecamethyl-16.4283-4.15139.5733

9
Compounds found in only two extracts
1.3423

-

0.6849

-
Hexanedioic acid, bis(2-ethylhexyl) ester
103,4-Dihydroxyphenylglycol, 4TMS derivative3.5736--0.1525
11Heptasiloxane, 1,1,3,3,5,5,7,7,9,9,11,11,13,13- tetradecamethyl-6.3661--2.2806
12Penicillic acid (2,5-Hexadienoic acid, 3-methoxy-5-methyl-4-oxo--0.505411.5193-
13Succinic acid, ethyl pent-4-en-2-yl ester-0.87010.5604-
145,6-Dihydropenicillic acid-7.19990.6153-
15Cholestan-5-en-3-ol piperidinomethyl ether-6.131.4362
16Phosphinic acid, (1,1-dimethylethyl)[4-(1,1-dimethylethyl)phenyl]--4.693415.0705-

17
Compounds found in only one extract
0.3478

-

-

-
Cytochalasin H
186-chlorohexanoic acid 3-methylbuttyl ester0.459---
19Furan, 2-(dichloromethyl)-tetrahydro-0.948---
20Hexanoic acid, 2-methyl-0.2581---
21Phthalic acid, 6-ethyl-3-octyl butyl ester1.1848---
222,5-Dihydroxybenzoic acid, 3TMS derivative6.1423---
232,3-Dimethyl-2-heptene-8.4199--
24Hexadecanoic acid, 1-[[[(2-aminoethoxy) hydroxy phosphinyl]oxy]methyl]-1,2-ethanediyl ester-0.6677--
255-Hydroxy-4-methoxy-5-(prop-1-en-2-yl)furan-2(5H)-one-0.5835--
262-Nonen-4-one-1.4811--
272-(4-Ethoxyanilino)-N-propylpropanamide, Ac derivative-1.0839--
28Butylphosphonic acid, 2-ethylhexyl propyl ester-37.468--
294-tert-Octylphenol, TMS derivative-10.892--
301H-Imidazole, 1-(1-oxooctadecyl)--0.5937--
312-(1-Methylpiperidin-2-yl) ethanol-0.7136--
324-(4-Hydroxyphenyl)-4-methyl-2-pentanone, TMS derivative-0.3224--
33Sydowinin A, 2TMS derivative-1.322--
34Hexanedioic acid, dioctyl ester-0.4746--
35Phenanthrene-10-ethanamine, 3-bromo-á-hydroxy-N,N-diheptyl-, O,O-diphenylphosphate-0.3118--
36Cyclodecasiloxane, eicosamethyl--1.624--
37Cyclopentane, 1-acetyl-1,2-epoxy---0.4226-
38Flucytosine--1.6921-
392-Benzyl-3-methoxycyclopropanecarboxylic acid, methyl ester--1.0194-
40Succinic acid, ethyl 4-methylhept-3-yl ester--1.8956-
415-Hydroxy-4-methoxy-3-(1-methoxypropan-2-yl)furan-2(5H)-one--0.3608-
42Erythritol--5.3667-
432,5-Furandicarboxylic acid, tetrahydro-, dimethyl ester--21.4686-
44Epinephrine, (á)-, 3TMS derivative--0.7011-
45l-Alanine, N-(3-fluorobenzoyl)-, heptyl ester--10.3966-
46Phthalic acid, butyl hex-3-yl ester--0.4355-
47Ethene-1,1-diamine, 2,2-dinitro---0.5094-
483-Cholestanol piperidinomethyl ether--0.4484-
49Pentanedioic acid, 1-(6-bromo-9-phenanthrenyl)-2-(diheptylamino)ethyl monoester--0.3404-
50Hexasiloxane, tetradecamethyl---2.5974-
51Tenuazonic acid---21.6718
52Tetratetracontane---0.1631
538-Cinnamoyl-5,7-dihydroxy-2,2,6-trimethylchromene, 2TMS derivative---2.8126
54Octyl tetracosyl ether---1.4379
55tert-Hexadecanethiol---0.921
56Hexadecane, 1-bromo----0.5355
57Heptacosane---0.8685
58Terephthalic acid, bis(2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoroheptyl) ester---1.7433
594-Hydroxybenzyl alcohol, 2TBDMS derivative---0.7761
602-(5-Bromo-pyridin-2-ylamino)-3,3,3-trifluoro-2-(4-methoxy-benzoylamino)-propionic acid methyl ester---1.1012
61N-(2-Hydroxy-4-nitrophenyl)-4-methoxybenzamide, TMS derivative---0.3732
62Octadecane, 1-iodo----0.531
63Hexadecane---0.2867
64Bis(2-ethylhexyl) phthalate---10.6541
65[1,3]-Oxazino[5,6-c]quinoline,3-(3,4-methylenedioxybenzyl)-5-trifluoromethyl-3,4(2H)-dihydro-7-methoxy----0.2634
66para-Isopropylbenzoic acid trimethylsilylester---0.5585
67Dodecane, 1-iodo----0.2764
681,4-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester---0.3119
69Dodecane, 3-methyl----0.0976
70Supraene---1.2095
71Phenol, 2-amino-4,6-bis (1,1-dimethylethyl)----0.3795
72Benzene, 1,1,1-[1-(bromomethyl)-2-methoxy-1-methyl-1-ethanyl-2-ylidene]tris----0.9267
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ghazi-Yaker, A.; Kraak, B.; Houbraken, J.; Nabti, E.-h.; Cruz, C.; Saadoun, N.; Houali, K. In Vitro Antioxidant and Antibacterial Activities of Ethyl Acetate Extracts of Ziziphus lotus Leaves and Five Associated Endophytic Fungi. Microorganisms 2024, 12, 2671. https://doi.org/10.3390/microorganisms12122671

AMA Style

Ghazi-Yaker A, Kraak B, Houbraken J, Nabti E-h, Cruz C, Saadoun N, Houali K. In Vitro Antioxidant and Antibacterial Activities of Ethyl Acetate Extracts of Ziziphus lotus Leaves and Five Associated Endophytic Fungi. Microorganisms. 2024; 12(12):2671. https://doi.org/10.3390/microorganisms12122671

Chicago/Turabian Style

Ghazi-Yaker, Amel, Bart Kraak, Jos Houbraken, El-hafid Nabti, Cristina Cruz, Noria Saadoun, and Karim Houali. 2024. "In Vitro Antioxidant and Antibacterial Activities of Ethyl Acetate Extracts of Ziziphus lotus Leaves and Five Associated Endophytic Fungi" Microorganisms 12, no. 12: 2671. https://doi.org/10.3390/microorganisms12122671

APA Style

Ghazi-Yaker, A., Kraak, B., Houbraken, J., Nabti, E.-h., Cruz, C., Saadoun, N., & Houali, K. (2024). In Vitro Antioxidant and Antibacterial Activities of Ethyl Acetate Extracts of Ziziphus lotus Leaves and Five Associated Endophytic Fungi. Microorganisms, 12(12), 2671. https://doi.org/10.3390/microorganisms12122671

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop